CURRICULUM VITAE Robert Strohal, MD - EWMA

______________________________ 

Address 

CURRICULUM VITAE 

Robert Strohal, MD 

business: home: 

Dept. of Dermatology and Venerology Schüttenacker 4b 

Federal University Teaching Hospital Feldkirch A-6800 Feldkirch 

Carinagasse 47 Austria 

A-6800 Feldkirch email: rusotos@aon.at 

Austria 

e-mail: robert.strohal@lkhf.at 

Phone+43/5522/303-9121,1200 

Fax: +43/5522/303-769121 

mobile +43/664/1142140 

3/2010 

1

3/2010 

Date/place of birth: December 23, 1959; Bludenz, Austria 

Marital status: married, 3 children, Sophie-Patricia, Tobias-Michael, Simon-Alexander 

� Education/Pre-Doctoral Experience 

1985 - 86 Theses at the Institute of General and Experimental Pathology, 

University of Innsbruck Medical School, title: Murine systemic 

Lupus erythematosus: cDNA cloning and sequencing of heavy and 

light chains mRNA of a monoclonal anti-DNA autoantibody 

1987 MD, University of Innsbruck Medical School, Innsbruck, Austria 

� Post-Doctoral Experience 

1988 Start of the residency in Dermatology at the Department of 

Dermatology I., University of Vienna School of Medicine 

1988/1990 Research visits at the NIH – lmmunology and Dermatology Branch, 

Bethesda, USA; Drs S. Katz/J. Stanley 

1991 Start of own research group "Molecular immunology of 

melanoma" at the Division of Immunology, Allergy and Infectious 

Diseases, University of Vienna School of Medicine 

1995 -1995 Special training in plastic surgery at the Division of Plastic 

Surgery, Department of General Surgery, University of Vienna School 

of Medicine 

1994/1995 Qualification as board-certified Dermatologist, Senior 

Physician/Attending at the Division of Immunology, Allergy and 

Infectious Diseases, Department of Dermatology, University of 

Vienna School of Medicine 

1999 Venia legendi, Univ-Doz. at the 

Department of Dermatology, University of Vienna School of Medicine 

2000 Tenure at the same Department 

2000 Sabbatical I.: Dystrophin as potential early tumor marker in non- 

melanoma and melanoma skin cancer (Cooperation: Prof. Bittner, 

Dept. of Anatomy II, Univ. of Vienna School of Med.) 

2001 Sabbatical II.: Melanoma antigen transduced autografts as a new form 

of tumor vaccine, European Commission Marie Curie Fellowship Cat. 

40 for experienced researchers (Cooperation: Dr. De-Luca, IDI 

Farmaceutici, Rom) 

2002 Establishment of a new Clinical Department of Dermatology and 

Venerology as Head of the Department (Primar), Federal University 

Teaching Hospital Feldkirch, Austria 

2006 Establishment of a new research institute (Vorarlberg Institute 

for Dermatologic Investigation and Treatment, VIDIT – a department of 

the VIVIT Research Center, Feldkirch, Austria) as Head of the 

Institute 

2

� Additional Certificates 

3/2010 

• Board Certification of the Austrian Society of Dermatology and Venerology, 

15.11.1995 

• Diploma, Dermatohistopathology; Austrian Society of Dermatology, June 1994 

• Diploma, Testing physician for clinical phase-3-4 trials; Austrian Society of Clinical 

Pharmacology, June 1996 

• Diploma, Dermoscopy, Austrian Society of Dermatological Post-Doctoral Education, 

22.9.1996 

• Diploma, Hospital Management, Austrian Medical Association, 11/1998-7/1999 

• Diploma, medical court expert, Austrian Medical Association, October 2001 

� Scientific Awards and Scholarships 

• Scholarship for excellent studies, University of Innsbruck, Medical School 

1984/1985 

• Otto Westphal Thesis-Award, German Society of Immunology 1985/1986, 

1.10.1987; Ulm, Germany 

• Emil-Boral Scholarship, Emil-Boral Foundation, 1/87 - 12/1988, Zurich, 

Switzerland 

• Travel Grant for the 2 nd Tricontinental Meeting JSID, SID and ESDR, Japanese 

Society of Investigative Dermatology, 28.10.1993, Kyoto, Japan 

• AESCA-Award, Austrian Society of Dermatology and Venerology, 2.12.1994, Vienna, 

Austria 

• Unilever-Award, Austrian Society of Dermatology and Venerology, 29.11.1998, Linz, 

Austria 

• University Award, Viennese Chamber of Economics, 2.11.1999 

• Marie Curie fellowship Cat. 40 for experienced researchers (MCFI-2000-001668), 

European Commission Program “Improving Human Potential”, 7/01, Brussels, 

Belgium 

• Auspitz-Award (co-author of the awarded publication), Austrian Society of 

Dermatology and Venerology; 1.12.2007, Vienna, Austria 

• Second poster price, CPC Meeting, 19.1.2010, Paris, France 

� Board Memberships of Scientific Institutions, Societies and Journals 

• Vorarlberg Medical Association (Vorarlberger Ärztekammer), vice-head of the 

physicians specialty group Dermatology and Venerology, responsibility: curia for 

employed physicians, since 5/03- 

• European Association of Dermato-Oncology (EADO), board secretary 10/03-5/09 

• Austrian Cancer Aid Society (Österreichische Krebshilfe) Section Vorarlberg, 

board member 2/04-11/08, executive board member since 12/08- 

3

• Society of Physicians in Vorarlberg, board member since 9/04: president 9/04- 

9/08, past-president since 10/08- 

• Austrian Society of Dermatology and Venerology (ÖGDV), associated board 

member 5/05-10/06, full member of the board since 11/06- 

• Vorarlberg Institute for Vascular Investigation and Treatment (VIVIT), board 

member since 3/06- 

• Austrian Delegate at the UEMS (Union European Medicines Specialists) at the 

European Commission in Brussels, since 11/06-, 

• Austrian Society for Treatment of Wounds (AWA), board member since 6/07: 

president 3/08-6/09, vice-secretary 6/07-2/08, past-president since 6/09- 

• Medical Faculty of the Free University for Human Sciences, Triesen, 

Liechtenstein, full member of the scientific board, since 8/07- 

• Jatros Dermatologie: Member of the Journal´s Scientific Board, since 11/03- 

• Zeitschrift für Wundbehandlung (Journal of Treating Wounds), member of the 

editorial board since 10/07- 

• Journal of Clinical Dermatology, member of the editorial board since 9/09- 

3/2010 

� Member of Working Groups, Task Forces and Organisational Bodies 

• Drug Counseling Board of the Federal University Teaching Hospital Feldkirch, 

board member, 2/04 – 3/07 

• The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis – 

GRAPPA, USA/Europe (www.grappanetwork.org), member since 11/04- 

• Working Group “Biologics in Dermatology” of the Austrian Society of Dermatology 

and Venerology, working chairman 5/05-11/07, chairman 12/07-11/09, vice chairman 

since 12/09- 

• Working Group “Occupational Dermatology” of the German Dermatology Society, 


• Interdisciplinary Tumor Board of the Federal University Teaching Hospital 

Feldkirch, board member since 2/04- 

• Assistant Board of the Chief Executive Committee (Beirat der 

Krankenhausleitung) of the Federal University Teaching Hospital Feldkirch, board 


• General Drug Counseling Board of the Federal Hospitals Bludenz, Hohenems, 

Bregenz, Maria Rast and the Federal University Teaching Hospital Feldkirch, board 


• Interdisciplinary Board “Treatment of Wounds” of the Federal University Teaching 

Hospital Feldkirch, medical head since 11/07- 

• Working Group “Evaluation of European Guidelines” of the UEMS, chairman 

since 11/08- 

4

� Advisory Boards/Expert Groups 

3/2010 

• Protopic ® in Atopic Eczema, Austrian clinical experts group 

(dermatologists/pediatricians), Astellas, member since 11/02-; meetings: 30.10.2003, 

12.11.2004, Vienna, Austria 

• The role of Alefacept in Psoriasis, Austrian advisory board meeting, Biogen, 

member, meeting 15.1.2003, Vienna, Austria 

• John Boswick Symposium on Burn and Wound Management, American advisory 

board meeting, Smith and Nephew Global, member, meeting 17.2.2003, Maui, 

Hawaii, USA 

• Enbrel ® in Psoriasis and Psoriatic Arthritis, Austrian advisory board, Wyeth 

Lederle Pharma, member since 3/03-, meetings: 1.4.2004 (co-chairman), 

• Dystrophic Epidermolysis Bullosa, 2 nd global advisory board, Smith and Nephew 

Global, guest member, meeting 2.2.2004, Washington DC, USA 

• The Role of Topical Steroids in Dermatology, Austrian clinical experts group, Update 

Europe, member, meeting 22.3.04, Vienna, Austria 

• The role of Infliximab ® in Psoriasis and Psoriatic Arthritis, Austrian advisory 

board (dermatologists/rheumatologists), Schering Plough/AESCA, member, 

meetings: 31.3.2004, Vienna, Austria; 10.6.2004, Bad Ischl, Austria 

• Raptiva ® and Psoriasis, Austrian clinical experts group, Serono, member, meeting 


• European Dermatology Expert Panel – Wyeth International, member since 4/05-; 

meetings: 15.-16.4.2005, Paris, France; 17.-18.6.2005, Rome, Italy; 15.-16.10.2005, 

London, UK; 23.-24.2.2006, Barcelona, Spain; 30.6.-1.7.2006, Copenhagen, 

Denmark; 2.-3.11.2006, Amsterdam, The Netherlands; 18.-20.4.2007, Berlin, 

Germany; 8.11.2007, Madrid, Spain; 21.2.2008, Rome; 26.6.2008, Amsterdam; 

19.11.2008, Vienna, Austria; 22.4.2009, Bucharest, Rumania; 17.3.2010, Mainz, 

Germany 

• Humira ® and Psoriatic Arthritis, Austrian advisory board, Abbott, member since 

11/05-; meetings: (Co-chair), 7.2.2008, 18.4.2009, Vienna, Austria 

• Early Recognition and Therapy of Allergy-Related Diseases for the General 

Physician – Development of a Consensus Statement, Austrian experts group 

(general physicians), Austrian Society of General Physicians together with Alk-Abello, 

invited as expert in allergology, meeting 20.9.2006, Vienna, Austria 

• Definition of Algorithms and Parameters for Austrian Reimbursement of 

Biologics in Dermatology, project group, Austrian Society of Dermatology and 

Venerology, member, meetings: 27.9. and 18.10.2006, Vienna, Austria 

• Tablet-Based Immunotherapy for Grass Pollen Allergies, Austrian clinical experts 

group (interdisciplinary), MED ahead Society for Medical Information, member, meeting 


• The Role of Calcipotriol/Betametason (Psorcutan-β ® ) in the Long-Term 

Treatment of Moderate Psoriasis, Austrian advisory board, MED ahead Society for 

Medical Information, member, meeting 25.1.2007, Vienna, Austria 

5

3/2010 

• National Curriculum and Certificate “Wound Management”, Austrian experts 

group (interdisciplinary), Austrian Medical Assotiation (Österreichische Ärztekammer), 

member, meeting 23.2.2007, Vienna, Austria 

• The Position of Brivudin in the Therapy of Herpes Zoster, Austrian experts group 

(interdisciplinary), MedMedia Publishing House, chair, meeting 20.7.2007, Vienna, 

Austria 

• Sclerodermic Digital Ulcers - Dual Register, Austrian advisory board 

(interdisciplinary), Actelion, member, meetings: 31.1. and 22.10.2008, Vienna, Austria 

• The Role of Polihexanid in the Treatment of Critically Colonized – Locally 

Infected Wounds, German/Austrian experts group (interdisciplinary), Lohmann and 

Rauscher Global, member, 30.3.2008, Vienna, Austria 

• Global Dermatology Advisory Board – Wyeth International, member since 7/09-; 

kick-off meeting: 24.-25.7.2009, Paris, France 

• The Role of Polihexanid for Wounds at Infection Risk, German/Swiss/Austrian 

experts group (interdisciplinary), Lohmann and Rauscher Global, member, 4.- 


� Teaching Responsibilities/Tutor for MD Theses 

• Molecular Biology and Dermatological Clinics, Course N° 529100, Medical University 

Vienna, SS (summer semester) 2000 – SS 2009 

• General Dermatology, School of Nursing, Federal University Teaching Hospital 

Feldkirch, SS 2002 – SS 2003 

• Specifics in Dermatology, Post-Graduate Teaching Series for MDs during their 

Internship, Federal University Teaching Hospital Feldkirch, since SS 2004- 

• Geriatric Dermatology, Post Graduate Diploma Course for Geriatric Medicine, 

Austrian Association of Physicians, Schloß Hofen Lochau, Austria, since SS 2005- 

• Morphometric Wound Analyses and Documentation: A comparative study of two 

digital computer-based systems, Dr. scient. med. thesis, author: C. Galitz, Medical 

Faculty of the Free University of Human Sciences in Liechtenstein in cooperation with 

the Medical University of Innsbruck, 9/09 

• Universitätslehrgang Wound Care Management der Paracelsus Medizinische 

Privatuniversität: „Interdisziplinärer Basislehrgang“ Studienjahr 2009/2010, 29.11.09, 

Salzburg; 

� Review Responsibilities 

• European Commission - 5 th , 6 th and 7 th EU Framework-Program 

- Selected by the European Commission as member and raporteur of the “2000 

Monitorinq panel für the Quality of Life Programme"; 11/00 - 6/01, Contract N° 

QLEV-2000-22630. 

- Expert (Reference N° EE19981AO0287) for the evaluation of RTD applications 

in several different areas and calls of the fp5 Quality of Life programme: 

Contract N° QLEV-CT99-00016 - Accompanying Measures (5/99); Contract N° 

QLEV-CT99-01040 - Generic Activities, Area 7.1, Chronic and Degenerative 

6

3/2010 

Diseases (7/99); Contract N° QLEV-CT99-01616 - final panel of Area 7.1, 

Chronic and Degenerative Diseases (7/99); Contract N° QLEV-1999- 08793 - 

Generic Activities, Area 7.2 and 7.3, Chronic and Degenerative Diseases (1/00); 

Contract N° QLEV-2000-20063 - chairman-rapporteur immunology/cancer of the 

final panel Area 7.2 and 7.3, Chronic and Degenerative Diseases (1-2/00); 

Contract N° QLEV-2000-22342 Accompanying Measures (7/00); Contract N° 

QLEV-2000-26716 – Generic Activities, Area 7.1, Chronic and Degenerative 

Diseases (11/00); Contract N° QLEV-2000-26406 - Key Action 3, Area 3.1 and 

3.2 (12/00); Contract N° QLEV-2000-28614 - final panel of Area 7.1, Chronic 

and Degenerative Diseases (12/00). 

- Expert (Reference N° EE19981AO0287) for the assessment and ranking of 

applications in the Expression of Interest (Eol) Call of the upcoming new fp6, 

Contract N° QLEV-2002-23930 (6/02). 

- Expert (Reference N° EE19981AO0287) for the evaluation of projects - midterm 

reviews: 26.3.04 Project QLG1-2002-01738, Contract letter CT- 

EX2002B014436-101; 

- Expert (Reference N° EX2002B014436) for the evaluation of projects: 10.1.10 

Call: FP7-HEALTH-1010-single-stage, Contract letter CT-EX2002B014436-102; 

• Dermatological Expert in Court 

• Ethic Committee of the Medical University in Graz, Austria 

• DEBRA Europe 

• Duhrig Böhler Award of the Society of Physicians in Vorarlberg 

• Scientific Award of the Vorarlberg Medical Association 

• Journal Reviewer 

- Journal of Investigative Dermatology 

- Applied Microbiology 

- Clinical and Experimental Dermatology 

- Journal of the German Society of Dermatology 

- Springer Verlag, Hamburg, New York 

- Expert Opinion in Biologic Therapy 

- British Journal of Dermatology 

- Wound Repair and Regeneration 

- Expert Opinion in Pharmacotherapy 

� Elected Memberships - Clinical/Scientific Societies 

• Society of Dermatological Research - ADF (Germany) 

• Society of Physicians in Vienna 

• German Dermatological Society - DDG; 

• European Society of Dermatological Research – ESDR 

• Austrian Society of Immunology and Allergy – ÖGAI 

7

• Marie Curie Fellowship Association – Platform of the European Commission for 

scientists having received a Marie Curie Fellowship 

• European Assotiation of Dermatology and Venerology – EADV 

3/2010 

� Laboratory-based Research Projects 

• In-situ immunophenotyping of the cutaneous melanoma-associated 

inflammatory infiltrate, sponsor: Commission of Cancer Research of the University 

of Vienna Medical School, 12/1/92 - 11/30/93 

• Molecular studies of the T-cell receptor gene repertoire and polymorphism from 

melanoma infiltrating lymphocytes, sponsor: Austrian Federal Bank- project No. 

4568, 5/1/93 - 5/30/95 

• Selectivity and transcription/expression kinetics of melanoma-associated 

antigens: potential for their regulation in-vitro and in-vivo, sponsor: Austrian 

Federal Bank- project No. 5562, 12/1/95 - 10/1/97 

• Oncogenesis of malignant melanoma – a molecular approach, sponsor: 

Commission of Cancer Research of the University of Vienna Medical School, 4/1/96 - 

3/31/98 

• Comparative studies on anti-tumor activities of Interferon-α2b and monopegylated 

Interferon-α regarding their immuno-modulating and antiproliferative 

effects on human melanocytes and melanoma cells, sponsor: 

AESCA, 10/1/1998 -12/31/1998 

• Delineation of the clonality of malignant melanoma via molecular mapping of 

melanoma-associated antigens, sponsor: University Foundation of the City of 

Vienna - project No. 54/98, 12/1/1998 - 12/31/1999 

• Induction of melanoma-based HLA, CD80 and tumor antigen expression by 

Interferon-α, sponsor: Austrian Federal Bank - project No. 7583, 1/1/99 - 3/1/00 

• Melanoma-associated antigens as potential tumor vaccines – a molecular 

approach, sponsor: University Award of the Viennese Chamber of Economics, 

2/11/99 -1/30/00 

• Melanoma antigen transduced autografts as a new form of tumor vaccine, 

sponsor: Marie Curie fellowship Cat. 40 for experienced researchers by the European 

Commission Programm “Improving Human Potential” – project MCFI-2000-001668, 

7/01 – 1/02 

• Dystrophin - a new potential biomarker for the malignant transformation of 

epithelial and melanocytic tissues, sponsor: Austrian Federal Ministry of 

Education, Science and Cultural Affairs, 10/00-3/02 

• In vitro, microbiological, pilot study of Acticoat ® as new anti-MRSA barrier or 

therapeutic option for external critically MRSA colonized wounds, sponsor: 

Smith + Nephew Austria, 4/02 - 6/02 

• Silver Dressings and MRSA – a comparative microbiological in-vitro trial, 

sponsor: Smith and Nephew Global, 11/03-4/04 

8

• The anti-microbial effect of the photodynamic, laser-based therapy - a preclinical, 

microbiological, in-vitro study, sponsor: Helbo Photodynamic Systems 

Austria, 12/05 - 1/06 

3/2010 

• Silver Dressings and MRSA – an up-dated, comparative, microbiological in-vitro 

trial, sponsor: Smith and Nephew Global , 6/06-9/06 

� Clinical Studies as Originating Author and Investigator In Charge 

• Sensitivity and specificity of the European standard block patch test 

formulations – a comparative approach, prospective single center comparative 

study, sponsor: Brial allergen, 8/02 - 4/03. 

• 5% topical Imiquimod for all kinds of basal cell carcinoma including large and 

high risk lesions, prospective open label single center follow-up study including 

histopathological examinations, sponsor: in part 3M Austria, 10/02 – 9/04 

• Anti-MRSA properties and barrier function of Acticoat ® , Austrian double-center 

prospective controlled study, sponsor: Smith and Nephew Global, 11/02 - 8/03 

• Topical Pimecrolimus versus Tacrolimus in patient with alopecia areata, an 

open label comparative study, sponsor: none, 1/03 – 5/04 

• Protopic-patch – sensitivity of nickel patch test reactions in Tacrolimus preloaded 

skin, prospective single center study, sponsor: Astellas Austria, 1/04-11/05. 

• The importance of hypersensitivity reactions against silicone for patients with 

cochlea implants, clinical prospective study as part of a KMT Tyrol, Austria, 

research cluster with Medel Austria and Prof. Wick (Institute for Pathophysiology, 

Medical University Innsbruck), sponsor: KMT and Medel, 4/05-11/06 

• Ethical questions and patients organizations, work package 9 of the European 

Commission framework program 6 concerted Action “Rare genetic skin diseases: 

advancing diagnosis, management and awareness through a European network”, 

acronym: GENESKIN, Proposal N° 512117, Consortium: 30 partners from 12 different 

European countries, sponsor: framework program 6 of the European Commission – 

project LSH 2003.2-1.1-7, 7/05-6/08 

• The global Acticoat ® Trial (CE/023/AC3): An open labeled multi-center study to test 

the barrier properties of the nanocrystalline silver dressing on MRSA colonized 

external acute and chronic wounds, 6 European centers, 2 US centers, sponsor: 

Smith and Nephew Global, 9/05-11/07 

• The anti-microbial effect of the photodynamic, laser-based therapy in external 

colonized and critically colonized wounds, prospective single center clinical pilot 

study, sponsor: Helbo Photodynamic Systems, 10/06-8/07 

• Pain reduction and anti-microbial efficacy of Suprasorb ® -X+PHMB compared to 

silver dressings, prospective, case-controlled, randomized, triple center clinical trial, 

sponsor: Lohmann and Rauscher Global, start 3/08- 

• A prospective open labeled study to evaluate the barrier and bactericidal 

properties of Acticoat ® in MRSA colonized wounds (CE/035/AC3), international 

double-center prospective controlled study, sponsor: Smith + Nephew Global, start 

3/08- 

9

3/2010 

• Efficacy of skin protection ointments versus skin care ointments in the metal 

processing industry, acronym: SPC, prospective comparative controlled 3-phases 

study at the locations Krefeld and Benrath of Thyssen-Krupp, Germany, sponsor: 

Evonic-Stockhausen, Germany, start 7/08-10/09 

• Reduction of itching and improvement of the skin by Cavilon ® skin protection 

cream in patients with anal skin irritation/eczema (3M-CAVAE-35-08), Austrian 

double-center, prospective, controlled study, sponsor: 3M Austria, 8/08-5/09 

• Tolerability and antimicrobial efficacy dynamics of Octenilin ® wound gel in 

critically colonized acute and chronic wounds (TAEDO-SMP-2-06/09), 

prospective single center clinical pilot study, sponsor: Schülke & Mayr Global, 5/09- 

10/09 

� Author or Assisting Author of Compassionate Use Studies (Anwendungsbeobachtungen) 

• Enbrel ® and Psoriatic Arthritis, Austrian compassionate use study by Wyeth- 

Lederle Pharma, assisting author, 10/03 – 2/04 

• Combination therapy of vitiligo with Vitix ® and UV-B narrow band, Austrian 

compassionate use study by Sanova, originating author, 4/04-3/05 

• Raptiva ® and Psoriasis, Austrian compassionate use study by Serono, assistant 

author, 10/03 – 2/04 

• Etanercept and conventional systemic therapies in the treatment of Psoriasis, 

compassionate use study for Austria and the eastern EU countries by Wyeth-Lederle 

Pharma, cooperative author of a non company-related group of authors, 10/03 – 2/04 

• 5% topical Imiquimod and actinic keratoses, Austrian compassionate use study by 

Meda Pharma, assisting author, 3/08-6/09 

� Lead Center of International Multi-Center Clinical Studies 

• A prospective pediatric longitudinal evaluation to assess the long-term safety of 

Tacrolimus ointment for the treatment of atopic dermatitis (APPLES, FHI 03-0- 

161/FG-506-06-37), Austrian lead center, sponsor: Astellas International, start 7/08- 

• A randomized, double blind trial assessing the efficacy and safety of Etanercept 

50mg twice weekly and Etanercept 50 mg once weekly for the treatment of 

moderate to severe psoriasis (N° 0881A6-4425), international multi-center study, 

global lead investigator together with Prof. Puig, Madrid, Spain, sponsor: Wyeth 

Global, start 3/08- 

� Multicenter, Company Sponsored Clinical Studies 

• A 22-week randomized, multicenter, parallel-group, double-blind study to compare a 

pimecrolimus 1% (Elidel) twice daily maintenance dosing regimen to a once 

daily maintenance dosing regimen in the management of atopic dermatitis in 

pediatric subjects, sponsor: Novartis International. 9/04 - 3/05 

10

3/2010 

• CRYSTAL: Continuous versus Intermittent Long-Term Etanercept therapy: a 

randomized efficiency and safety trial in psoriasis (0881A6-101764), sponsor: Wyeth 

International Philadelphia, USA, 3/05 - 4/07 

• A multicentre, open-label phase IIIb/IV study of subcutaneously administered 

Efalizumab in the treatment of adult patients with moderate to severe chronic 

plaque psoriasis who have failed to respond to, or who have a contraindication to, or 

are intolerant of other systemic therapies including cyclosporin, methotrexate and 

PUVA, sponsor: Serono Global, 6/05 - 11/07 

• An open-label, randomized efficiency and safety study of Infliximab versus 

Methotrexate in the treatment of moderate to severe psoriasis (P04271), 

sponsor: Schering Plough International, 10/05 - 10/06 

• Randomized, multicenter phase Ill trial comparing adjuvant treatment with Peglntron 

36 months versus Intron A over 18 months in melanoma AJCC stage II patients, 

organizer: European Association of Dermatooncology, sponsor: Schering Plough 

International, 6/03 - 1/08. 

• Randomized, multi-center, open label study to compare the efficiency and tolerability 

of pegylated-α-2a (PEG-IFN) to “low dose” Interferon-α-2a in patients with 

malignant melanoma in stages IIA (T3a) – IIIB (AJCC-2002), organizer: ADO 

(German Task Force Dermatooncology), sponsor: Roche International, 8/04-8/07 

• A long-term efficacy and safety study of Infliximab in the treatment of moderate to 

severe plaque-type psoriasis (P04563-06), sponsor: Schering Plough International, 

05/06 - 11/08 

• Long-term effects of Aldara ® 5% cream and Soleraze ® 3% gel in the treatment of 

actinic keratosis on the face or scalp (LEIDA). International, double-blind, 

randomized multicenter study, sponsor: MEDA Pharmaceuticals Central, start 6/08- 

� Compassionate Use Studies 

• Intron-A (Peglntron ® ) low dose treatment in patients with malignant melanoma 

of tumor thickness > 1.5 mm, AESCA Austria, 4/02 - 12/03 

• Effectivity and safety of high dose IFN-α �(Intron-A ® ) adjuvant therapy for stage 

III malignant melanoma, AESCA Austria, 4/02 – 5/08 

• Alefacept and Psoriasis, Biogen Austria, 10/03 - 7/04 

• Enbrel and Psoriatic Arthritis, Wyeth Austria, 1/04 - 7/04 

• Elidel and atopic dermatitis, Novartis Austria, 1/04 - 5/04 

• A combinational regimen of Vitix and UV/B narrow-band in Vitiligo patients, 

Sanova Austria. 2/04-3/06 

• Lamisil and Onychomycosis, Novartis Austria, 6/04 - 10/04 

• Bexaroten Gel and Mycosis fungoides stage I, Zeneus Pharma Europe, 6/04 - 

1/06 

• Efficacy and safety of Psorcutan-beta ® as initial treatment and Psorcutan ® 

ointment as follow-up treatment of psoriatic lesions, Intendis Austria, 2/06 - 5/06 

11

• Efficiency and safety of Tagretin tablets for the treatment of cutaneous T-cell 

lymphoma, Zeneus Pharma GmbH, 7/06 - 6/08 

3/2010 

• IMPACT – Etanercept therapy for moderate to severe Psoriasis vs. conventional 

systemic therapy, multinational program (Austria, Slovenia, Slovakia, Poland, 

Hungary), Wyeth Austria, 08/06-2/08 

• Avelox and Cellulitis, Bayer Medicals Austria, 1/07-6/07 

• DUO- register for patient with acral ulceration from scleroderma treated with 

Tracleer, Actelion GmbH, start 9/08- 

• Qualitiy of life of psoriasis patients who are unresponsive to other biologics 

than adalimumab after 1 year of adalimumab treatment, Abbott, start 10/08- 

• Double blind, randomized, placebo-controlled phase III study to test the 

efficacy of recMAGE-3 + AS15 as adjuvant therapy of patients with MAGE-3 

positive resected stage III melanoma, Glaxo-Smith Klein, start 12/09 

� Development of Studies and Programs for the Industry 

• DERM-OCC: A skin safety and disease prevention program for the industry: 

- Austrian Mineral Oil Association, pilot study at all Austrian locations 

(assessment of 1,470 industrial workers), 1/01 - 12/01 

- Suchard-Jakobs, Bludenz, Austria, 3/03 

- Hefel-Bau, Lustenau, Austria, 6/03 

- Suchard-Jakobs, Bludenz, Austria, third year follow-up study, 5/06 

- Wildbachverbauung Vorarlberg, Bludenz/Bregenz, Austria, 5/07-6/07 

- Hefel-Bau, Lustenau, Austria, fourth year follow-up study, 9/07 

- Sparkasse, Bregenz, Austria, 11/08 

- All hospitals of the Hospital Management Company Vorarlberg (Bludenz, 

Hohenems, Rankweil, Maria-Rast, Bregenz and the Federal University 

Teaching Hospital Feldkirch, start 1/09- 

• Program for the identification and implementation of process-oriented skin 

safety standards in the oil and gas industry, Austrian Mineral Oil Association, 

locations Schwechat and Gänserndorf, Austria, 5/03-2/06 

• UV-light workplaces, Evaluation of dangers, biological read-out, development and 

implementation of security measures, Swarovsky Triesen, Liechtenstein, 5/04-11/05. 

• A program to test the skin safety of cosmetic skin products, series Edelweiss, 

ENJO, Altach, Austria, 9/08 

• Development and maintenance of a specific alert system for monitoring and 

treating adverse events due to the use of cosmetics, Turimed, Willilesen, Swiss, 

11/08; Metzler, Egg, Austria 1/09 

12

� Developments/Patents 

• SKINWORKS Cream, Balsam and Lotion – Combined sun and cold protection for 

winter mountain sports activities. 

• ACTIVAN Cream, Fat-Cream and Lotion – Combined sun protection and 

occupational skin care for professional out-door workers. 

3/2010 

• DERM-OCC – a program for the identification, definition and implementation of skin 

protection measures in the oil and gas industry. 

• Development of new sun-screen preparations. In cooperation with Plantapharm 

Austria and Plegé Cosmetics Austria, 5/03-3/06 

• SkinWork as potent cold and UV-radiation protection for professional, world leading 

biathletes. In use test study with the national biathlete teams of Austria, Germany, 

Ukraine, Canada, Norway, Bulgaria and Slovenia. International Biathlete Union (IBU), 

10/06, Ramsau, Austria 

• BIOMED – Establishment of a Vorarlberg Competence Center for Biomedical 

Diagnostics and Research, EFRE Grant by the European Commission and the 

Government of Vorarlberg, Consortium: Prof. Drexel, Head of the Department of 

Medicine and Director of VIVIT, Dr. Lang, Head of the Division of Oncology, Dept. of 

Medicine and Prof. Simma, Head of the Department of Pediatrics, University 

Teaching Hospital of Feldkirch and VIVIT, start: 4/06-10/07 

� Orqanisation and Co-Organisation of Congresses/Meetings/Symposia 

• B-cells and autoimmunity: New concepts and therapeutic perspectives, IUIS- 

SSI, Satellite Meeting, Scientific Board, 19.-21.7.2001, Bergen Norway 

• Malignant Melanoma – update, Society of Physicians in Vorarlberg, Symposium, 

main organizer, 26.4.2003, Feldkirch, Austria 

• Enbrel ® – from Rheumatoid to psoriatic arthritis, Wyeth Austria, Symposium, coorganizer 

with the company, 4.9.2003, Vienna, Austria. 

• CURRICULUM Type I Allergy: Diagnosis, Therapy and Hands-on Workshop, 

Symposium, initiator and co-organizer with Prof. Dr. N. Reider, Dept. Dermatology, 

University of Innsbruck, Austria, Dr. Elsässer, Dept. of Otology, Federal University 

Teaching Hospital Feldkirch, and Alk-Abello, Austria, 5.11.2003 Innsbruck and 

29.11.2003, Dornbirn, Austria. 

• Diabetic foot syndrom – an interdisciplinary challenge, Smith and Nephew 

Academy, lecture program, co-organizer with Dr. Lahnsteiner Smith and Nephew, 

March to June, 2004, Vienna, Graz, Salzburg and Innsbruck, Austria 

• Multidisciplinary Symposia, Seminars, Lectures (altogether 94), Society of 

Physicians in Vorarlberg, co-organizer as president of the Society, 9/04 - 9/08 

• DERM-OCC III/Phase 2: Teaching Symposium “Train the Trainers” – Training 

activities with regard to skin protection measures for all workers in the Austrian 

Mineral Oil Association, initiator and main organizer, 22.2.2005, Feldkirch, Austria. 

13

• Biologics – a new generation of drugs in medicine, Symposium, Society of 

Physicians in Vorarlberg, initiator and main organizer, 18.3.2005, Dornbirn, Austria 

3/2010 

• Annual Meeting of the Society of Physicians in Vorarlberg with the award of the 

Duhrig-Böhler Prices, main organizer, 2.6.2005, 6.7.2006, 10.9.2007, 23.9.2008, 

Feldkirch, Austria 

• Slowakien Teaching Symposium on the use of Etanecept in Psoriasis and 

Psoriasis Arthritis, co-organizer with the company, 3.12. 2005, Bratislawa, Slowakia 

• Kick-off Symposium for the Global Acticoat ® trial: An open labeled multicenter 

study to test the barrier properties of Acticoat ® on MRSA colonized external acute and 

chronic wounds, Smith and Nephew, co-organizer with the company, 24-25.2.2006, 

Vienna, Austria 

• 1 st Lake Konstanz four country symposium: New Trends in Allergology, Society 

of Physicians in Vorarlberg, initiator and co-organizer with Dr. Elsässer, Dept. of 

Otology, Federal University Teaching Hospital Feldkirch, 10.-11.11.2006, Bregenz, 

Austria 

• Biologics in Dermatology – a teaching symposium, Working Group “Biologics in 

Dermatology” of the Austrian Society of Dermatology and Venerology, co-organizer 

with Prof. Pehamberger, Department of General Dermatology, Medical University of 

Vienna, 4.-5.5.2007, Vienna, Austria 

• 9 th Annual Meeting of the Austrian Society for Treatment of Wounds (AWA) and 

1 st combined Annual Meeting of the Austrian AWA and the Swiss Association 

for Treating Wounds (SafW), main organizer as congress president, 1.-2.6.2007, 

Bregenz, Austria 

• 2 nd Lake Konstanz four country symposium: New Trends in Allergology, Society 

of Physicians in Vorarlberg, co-organizer with Dr. Elsässer, Dept. of Otology, Federal 

University Teaching Hospital Feldkirch, 14.-15.11.2008, Bregenz, Austria. 

• 11 th Annual Meeting of the Austrian Society for Treatment of Wounds (AWA) 

and 2 st combined Annual Meeting of the Austrian AWA and the Swiss SAfW, 

main organizer as president of the AWA, 19.-20.6.2009, Zurich, Switzerland 

� Invited Lectures, Workshops, Round Table Discussions and Chairs 

• Are autoantigens encoded in the immunoglobulin loci? V. Winter Round-Table 

Conference on Controversial lmmunology, 25.4.1987, Kühtai, Austria 

• Die molekulare Genetik als Werkzeug der dermatologischen Klinik (The repertoire of 

molecular genetics as important tool for the dermatological clinic), Guest Lecture 

Department of Dermatology, Univ. of Erlangen School of Medicine, 19.2.1992, 

Erlangen, Germany 

• The T -Cell receptor repertoire of Iymphocytes infiltrating cutaneous melanoma is 

predominated by Vα specificities present in T -cells of normal skin, Lecture at the 2 nd 

Tricontinental Meeting of the SID, JSID and ESDR, 30.10.1993, Kyoto, Japan 

• Subkorneale pustulöse Dermatose (Sneddon-Wilkinson) mit isolierter IgA-Kappa 

Paraproteinämie. Case presentation at the Annual Meeting of the Austrian 

Society of Dermatology and Venereology, 2.-4.12.1994, Vienna, Austria 

14

3/2010 

• Genetische Aspekte des Melanoms (The genetics of melanoma), Symposium of the 

Society of Physicians in Vienna, 3.5.1995, Vienna, Austria 

• CMV und Herpesvirusgruppe: Potentielle agonistische und antagonistische 

Interaktionen im Rahmen der HIV-lnfektion (CMV and Herpes group – potential 

agonistic and antagonistic actions on the basis of an HIV infection), Symposium of 

the Austrian AIDS-Society, 11.11.1995, Vienna, Austria 

• Immunotherapy of malignant melanoma, 4 th GCC International Conference of 

Dermatology and Venereology; 4.-6.3.1997, Kuwait City, Kuwait 

• New therapeutic approaches in the treatment of malignant melanoma, 4 th 

International Congress on Dermatology and Leprosy, 8.-10.10.1997, Teheran, 

Iran 

• Der Ausschlag - Ein arbeitsmedizinisches Problem? (Dermatitis – a problem of 

occupational medicine?), Guest Lecture at the Center for Occupational Medicine 

of the Red Cross Organisation, 14.5.1998; Vienna, Austria 

• Qualitative und quantitative Analysen der in-situ Immunantwort des malignen 

Melanoms (Qualitative and quantitative analyses of the melanoma-associated in-situ 

immune response), Guest Lecture at the Department of Dermatology, Univ. of 

Erlangen School of Medicine, 16.6.1999, Erlangen, Germany 

• Wie viel Wirkkosmetik braucht der Mensch? (How much cosmetics needs a human 

being?), HAGE-III, Joint Meeting of Stake-Holders and Experts in the Field of 

Cosmetology, 23.2.2001, Hannover, Germany 

• Erfahrungsbericht eines Evaluators (Experiences from an external reviewer for the 

European Commission), BIT Symposium: European Commission-funded 

Research, 18.7.2001, Vienna, Austria 

• Evaluation of EC Proposals, Kick-off meeting TRAIN-NET by BIT, 14.9.2001, 

Budapest, Hungary 

• Sicherheit am Arbeitsplatz – die Sicht des Arztes (Security at the work place - the 

doctors view), Annual Meeting of the OMV Occupational Safty and Security 

Board, 6.11.2001, Vienna, Austria 

• Die Dermatologie als Teil der Medizin (Dermatology as part of general medicine), 

Inauguration for the New Department at the Federal University Teaching Hospital 

Feldkirch, 4.3.2002, Feldkirch, Austria 

• Die schwere Akne als therapeutische Herausforderung (Severe acne as a therapeutic 

challenge), Roche Seminar for Family Doctors, 23.5. and 25.11.2002, Dornbirn, 

Austria 

• Braun sein - und trotzdem gesund? (Tanned and still healthy?), Health Day Initiative 

HLW Rankweil, 24.5.2002, Rankweil, Austria 

• Neurodermitis und Psoriasis - Pathogenese, Klinik, therapeutische Möglichkeiten 

(Atopic ekzema and psoriasis – pathogenesis, clinic and therapeutic options), 

Meeting of the Vorarlberg Society of Pharmacists, 26.6.2002, Dornbirn, Austria 

• Die klinische Dermatologie - ein neues Gesundheitsangebot in Vorarlberg (Clinical 

dermatology – a new health care offer in Vorarlberg), Meeting of the Association of 

Practitioners and Family Doctors, 4.7. and 13.10.2002, Bludenz, Bregenz, Austria 

Austria 

15

3/2010 

• Die Silbertechnologie – neue Entwicklungen und Aussichten (Silver Technology - 

New Developments and Perspectives), Annual Report Meeting of Smith & Nephew 

Austria, 16.1.2003, Vienna, Austria 

• Acticoat ® as potent barrier against the spread of MRSA, Guest Lecture at the John 

Boswick Symposium on Burn and Wound Management, 17.2.2003, Maui, Hawaii, 

USA 

• Die Wundbehandlung in der allgemeinen Medizin (Wound management in general 

medicine), Educational Wound Care Symposium, 11.3.2003, Bregenz, Austria. 

• Neue Therapiemöglichkeiten für das atopische Ekzem (New therapeutic options for 

atopic eczema), Lecture for Family Doctors, 27.3.2003, Dornbirn, Austria 

• Hennatatoos und die allergologischen Implikationen (Hennatatoos and the 

allergologic implications), 7 th Round table Meeting on Allergology, 3.3.2003, 

Innsbruck, Austria 

• Acticoat ® als neue Barriere- und/oder Behandlungsoption bei MRSA kolonisierten 

Wunden (Acticoat ® as new barrier and/or therapeutic option in MRSA colonized 

wounds), 5 th Annual Meeting of the AWA, 3.4.2003, Innsbruck, Austria 

• Biologika als neue therapeutische Option für die moderate bis schwere Psoriasis 

(Biologics as a new therapeutic option for moderate to severe psoriasis), Wyeth 

Symposium for the Vorarlberg Association of Dermatologists, 15.5.2003, 

Dornbirn, Austria, 

• Acticoat ® and MRSA or, how to expand markets. Best Practice Meeting Smith and 

Nephew Global, 20.5.2003, Pisa, Italy 

• Das Basaliom (Basal cell carcinoma), 12 th Meeting of the Austrian Academy for 

Dermatologic Education, 20.6.2003, Mondsee, Austria 

• Das Spektrum der Dermato-Venerology (The spectrum of Dermato-Venerology), 

Evening of the Rotary Club Feldkirch, 19.8.2003, Feldkirch, Austria 

• Psoriasisarthritis up-date (Psoriatic arthritis up-date), lecture and chair, Wyeth 

Symposium for Austrian Dermatologists, 4.9.2003, Vienna, Austria 

• Nanokristalline Silberwundauflagen und MRSA (Nanocristalline silver dressings and 

MRSA). Annual Infection Control Round Table Meeting of the ÖGKV and 

ÖGHMP, 16.9.2003, Vienna, Austria 

• Das klinische Spektrum der Dermato-Venerology (The Clinical Spectrum of Dermato- 

Venerology), Guest Lecture for the Association of Practitioners and Family 

Doctors, 22.9.2003, Hard, Austria 

• Skin protection and the food industry, Guest Lecture at Suchard-Kraft Food, 

23.10.2003, Lörrach, Germany 

• The multiple images of Imiquimod in Dermato-Venerology, Seminar Skin Dialog 

Pelpharma, 10.10.2003, Venice, Italy 

• Imiquimod and non melanoma skin cancer, EADO Satellite Symposium at the 

Annual Meeting of the European Assotiation of Dermatology and Venerology, 

15.10.2003, Barcelona, Spain 

• Wound.net@vorarlberg - a new dimension in wound care. 5 th Update and Advances 

in Wound Care Meeting Johnson + Johnson, 27.1.2004, Arosa, Switzerland. 

16

• Sonne ohne Reue (Sun without remorse), Evening of the Rotary Club Feldkirch, 

2.3.2004, Feldkirch, Austria 

3/2010 

• Is the sun our friend or enemy (Ist die Sonne unser Freund oder Feind), Feldkircher 

Physician´s Seminar Series, 7.4.2004, Feldkirch Austria 

• DERM-OCC – ein neues Präventions- und Hautsicherheitsprogramm für die Industrie 

(DERM-OCC - a new prevention and safety program for the industry), Guest Lecture 

at OMICRON, 16.4.04, Klaus, Austria. 

• Setting new benchmarks for HAI and MRSA, Symposium Series UK Smith + 

Nephew Academy, 27.-29.4.2004, London, Birmingham and Glasgow, UK 

• Sonne ohne Reue und Sexuell übertragbare Krankheiten (Sun without remorse and 

sexually transmitted disease), Guest Lecture at the Vorarlberg Federal Pedagogic 

Institute, 4.5.2004, Feldkirch, Austria 

• Dermatology and microbiology, Symposium Series Austrian Smith + Nephew 

Academy, 22.5.2004 Vienna and 26.6.2004 Innsbruck, Austria 

• Diaklinik (Dermatological slide show) of the Department of Dermatology, Federal 

University Teaching Hospital of Feldkirch for the Vorarlberg Medical Association of 

Dermatologists in Office, 25.5.2004, Feldkirch, Austria 

• Acticoat ® dressing as an efficient MRSA barrier: a new solution to an increasing 

problem, Exhibitor Symposium at the Association for Professionals in Infection 

Control and Epidemiology (APIC 2004), 7.6.2004, Phoenix, USA 

• Anaphylaxie (Anaphylaxis). Post-Graduate Training Program for Physicians, 


• Paradigmen der Externatherapie (Paradigms of topical therapy), Guest Lecture at 

the Center of Occupational Medicine, Austrian Mineral Oil Association, 

22.6.2004, Schwechat, Austria 

• Acticoat ® and MRSA, Congress of the World Union of Wound Healing Societies 

S+N Satellite Symposium, 9.7.2004, Paris, France 

• Weaknesses and strengths of Imiquimod in epithelial skin cancers – the clinician´s 

view, Symposium Forum Biotechnology, International Skin Cancer Congress, 

22.7.2004, Zurich, Switzerland 

• Rational for the development of a new PEG-Intron formulation, EADO Study Group 

Meeting at the International Skin Cancer Congress, 23.7.2004, Zurich, 

Switzerland 

• Setting new benchmarks for HAI and MRSA. Invited Lecture, Symposium Series UK 

Smith + Nephew Academy, 28.9. Newcastle and 30.9.2004 Manchester, UK 

• Silver technology – from the bench to clinics. Series of Lectures (Lecture Tour), 

USA Smith + Nephew Academy, 25.-29.10.2004, 6 meetings at Los Angeles, 

Chicago, Atlanta, New York and Washington, USA 

• Change of paradigms in the treatment of atopic eczema, Astellas Educational 

Lecture for Dermatologists and Pediatricians, 4.11.2004, Bregenz, Austria 

• Imiquimod and non-melanoma skin cancer, EADO Satellite Symposium at the 

Annual Meeting of the European Association of Dermatology and Venerology 

(EADV), 17.11.2004, Florence, Italy 

17

3/2010 

• Stigmata der Haut (Skin signs) and Melanomprävention (Melanoma prevention), First 

Vorarlberg Skin Caring Day for Health Care Professionals. 26.11.2004, Feldkirch, 

Austria 

• DERM-OCC II – phase 1 and 2: Präsentation der Ergebnisse (Presentation of results, 

follow-up activities, full company roll out), Austrian Mineral Oil Association Board 

of Directors Quarterly Meeting, 26.11.2004, Vienna, Austria 

• Sexuell übertragbare Krankheiten (Sexually transmitted diseases), Post-graduate 

Training Program for Physicians. 13.1.2005, Feldkirch, Austria 

• Typ-1 Allergien - Immunologie, Epidemiologie und Prävention (Type-1 allergies - 

immunology, epidemiology and prevention), Symposium and Workshop for 

Pediatricians by the Society of Physicians in Vorarlberg, 15.1.2005, Dornbirn, 

Austria 

• Coronary and Atherosclerosis/peripheral arterial occlusion disease, Symposium by 

the Society of Physicians in Vorarlberg and the VIVIT Research Institute, chair 

and moderator, 26.2.2005, Feldkirch, Austria 

• Biologika – eine neue Generation von Medikamenten (Biologics – a new generation 

of drugs in medicine), Symposium of the Society of Physicians in Vorarlberg, 

lecture and chair, 18.3.2005, Dornbirn, Austria 

• TEN (Toxic epidermal necrolysis), Post-graduate Training Program for 

Physicians, 31.3.2005, Feldkirch, Austria 

• MRSA – Strategien der Dekolonisierung (Strategies for de-colonization), Wound- 

Management Seminar at the 43 th Annual Meeting of the German Dermatologic 

Society, 21.4.2005, Dresden, Germany 

• Allergien – was, wann, wie und gibt es eine Heilung (Allergies – who, what, when and 

is there a cure?), Annual Meeting of the Nursing Association Koblach, 28.4.2005, 

Koblach, Austria 

• Out-door work as potential risk for melanoma, EADO Symposium at the 10 th World 

Congress on Cancers of the Skin. 14.5.2005, Vienna, Austria 

• Putting promise into practice: biologics in the treatment of psoriasis, Wyeth Satellite 

Symposium at the 3 rd EADV Spring Symposium, 20.5.2005, Sofia, Bulgaria 

• Biologika in der Dermatology (Biologics in Dermatology), 13 th Meeting of the 

Austrian Academy for Dermatologic Education, 27.5.2005, Mondsee, Austria 

• Allergien – was, wann, wie und gibt es eine Heilung (Allergies – who, what, when and 

is there a cure?), UNIQA Health Care Club, 7.6.2005, Feldkirch, Austria 

• The concept of local MRSA management, Series of Lectures (Lecture Tour), 

Canada Smith + Nephew Academy, 7.-10.9.2005, Calgary, Winnipeg, Toronto, 

Ottawa, Montreal and Halifax, Canada 

• Management strategies for Psoriasis, Wyeth Educational Lecture Series for the 

Hong Kong Society of Family Physicians and Hong Kong Society of 

Dermatologists, 13.-14.9.2005, Hong Kong, China 

• Das Problem der alternden Haut (The problem of aged skin), Weekly Meeting of the 

Roman Catholic Aged Community in Tisis, 15.9.2005, Feldkirch, Austria. 

• Biological Therapies for psoriasis and psoriatic arthritis, Wyeth Eastern-European 

Kick-off Meeting, 19.9.2005, Vienna, Austria 

18

• Nanocristalline silver dressings and MRSA, Smith and Nephew Satellite 

Symposium at the Annual Meeting of the Italian Society of Wound Care, 

22.9.2005, Turin, Italy 

• Ein Start für die molekularbiologische Forschung in Vorarlberg (A dawn for the 

molecular biological research in Vorarlberg), Symposium of the Society of 

Physicians in Vorarlberg and the VIVIT Institute, closing remarks, 28.9.2005, 

Dornbirn, Austria 

3/2010 

• Local MRSA management – a new solution to an increasing problem, Symposium of 

the Nordic Scientific Meeting on Wound Healing, 6.10.2005, Copenhagen, 

Denmark 

• Out-door work as potential risk for melanoma, EADO Sister Society Symposium at 

the 14 th EADV Congress, 12.10.2005, London, UK 

• Die Rolle von Humira bei der Psoriasisarthritis – eine Umfrage bei Dermatologen 

(The role of Humira in psoriatic arthritis – a survey with dermatologists), Kick-off 

Meeting of the Abbott Austrian Advisory Board, 11.11.2005, Vienna, Austria 

• Gallensteine – was ist zu tun? (Stones of the biliary duct – what to do?) 1 st Internet- 

Videoconference of the Society of Physicians in Vorarlberg with the Society of 

Physicians in Vienna, welcome remarks, 9.11.2005, Feldkirch and Vienna, Austria 

• Der Einfluß von Tacrolimus 0,1% auf die Epikutantestreaktion mit Nickel (Protopic- 

Patch – The impact of Tacrolimus 0.1% on the nickel patch test reaction), Astellas 

Symposium at the Annual Meeting of the Austrian Society of Dermatology and 

Venerology, 26.11.2005, Vienna, Austria 

• Biologic therapies for psoriasis and psoriatic arthritis, Wyeth Teaching Symposium 

for Slovak Dermatologists, 3.12.2005, Bratislava, Slovakia 

• Allergien – ihre Bedeutung und wie sie behandelt werden können (Allergies - their 

impact, role and how to treat them), Evening Meeting of the Lions Club Feldkirch, 


• Die Effloreszenzenlehre (The structure of skin lesions), Post-graduate Training 

Program for Physicians, 19.1.2006, Feldkirch, Austria 

• DERM-OCC – ein neues Präventions- und Hautsicherheitsprogramm für die Industrie 

(DERM-OCC - a new prevention and safety program for the industry), Guest lecture 

at HILTI International, 24.1.2006, Schaan, Liechtenstein 

• What is new on a global scale, Meeting of the Austrian Wyeth Advisory Board, 

lecture and co-chair, 2.2.2006, Vienna, Austria 

• Ulcus cruris and strategies for MRSA de-colonization, 2 nd Munich Interdisciplinary 

Symposium on Wound Healing. 10.3.2006, Munich, Germany 

• Der medizinische Ansatz zur Behandlung chronischer Wunden (The Medical 

Approach to Chronic Wounds), Meeting of the District Bregenz Family Doctors 

Quality Circle, 16.3.2006, Bregenz, Austria 

• Die Entwicklung neuer Hautschutzstandards für die Industrie (Development of new 

skin care standards for the industry), Guest Lecture at Evonic-Stockhausen, 

21.3.2006, Krefeld, Germany 

• Strategien der MRSA Dekolonisation von Wunden (Strategies for the MRSA decolonization 

of wounds), 1 st Interdisciplinary German Wound Symposium, 

1.4.2006, Mainz, Germany 

19

3/2010 

• Development and Implementation of Process oriented Skin safety Standards for the 

Mineral Oil Industry: A Pilot Study. Human Factors Symposium of the 8 th 

International Conference on Health, Safety and Environment, Society of Petrol 

Engineers, 3.4.2006, Abu Dhabi, United Arab Emirates 

• Sonne ist okay – aber bitte richtig (Sun – that´s okay, but please do it right), UNIQA 

Health Care Club, 6.4.2006, Feldkirch, Austria 

• Local MRSA management of acute and chronic wounds – what is next, Smith + 

Nephew Headquarters Strategy Meeting for the Life Cycle of Silver Dressings in 

the Field of Infection Control, 13.4.2006, Hull, UK 

• Sonne und Hautkrebs – eine gefährliche Partnerschaft (Sun and Skin Cancer – a 

dangerous partnership), Public Lecture of the Vorarlberg Cancer-AID Society, 

4.5.2006, Frastanz, Austria 

• Optimizing the management of psoriasis with biologics and new insights into the use 

of Etanercept, Lecture and Workshop at the 2 nd Wyeth Psoriasis Summit of 

Middle East and North Africa, 11.5.2006, Cairo, Egypt 

• Entwicklung und Anwendung von prozessorientierten Sicherheitsstandards für die 

Haut in der Mineralölindustrie: Eine Pilotstudie (Definition and Implementation of 

work-phase adapted skin protection measures for the oil and gas industry – a pilot 

study), 8 th International Skin Protection Day, 16.5.2006, Krefeld, Germany 

• Die Haut – Mantel des Körpers und der Seele (The skin – a specific coat for our body 

and soul), MINIMED Teaching Series. 6.6.2006, Wolfurt, Austria 

• Local MRSA management: A new solution to an increasing problem, Meeting of the 

Polish Burn Society, 9.6.2006, Poznan, Poland 

• Out-door work as potential risk for melanoma? 3 rd Meeting of the European 

Association of Dermato-Oncology (EADO), chair and lecture, 25.6.2006, Rome, 

Italy 

• Hyposensibilisierung von Typ-1 Allergien (Hyposensitisation of type-1 allergies), 

Multidisciplinary Educational Lecture for Physicians, 11.9.2006, Bregenz, Austria 

• Die Genetik des malignen Melanoms (The genetics of malignant melanoma), Annual 

Oncology Meeting of the Society of Physicians in Vorarlberg, 15.9.2006, Götzis, 

Austria 

• Hautschutz und die Nahrungsmittelindustrie: Bericht der Resultate einer 3-Jahres 

Nachsorgestudie (Skin protection and the food industry – Report on the results of the 

3 year follow up study), Guest Lecture at Suchard-Kraft Food, 26.9.2006, Bludenz, 

Austria 

• Immunologic treatment in NMSC, Symposium 18 at the 15 th Annual EADV 

Meeting, 6.10.2006, Rhodes, Greek 

• Strategien zur Dekolonisierung von MRSA Wunden (Strategies for the MRSA decolonization 

of wounds). Symposium of the Paul-Ehrlich Society and the 

Katharinen Hospital, 10.10.2006, Stuttgart, Germany 

• Has silver affected the thread of MRSA? Wound Symposium at the Annual VEITH 

Congress of the US Society of Vascular Surgeons, 15.11.2006, New York, USA 

20

• Entwicklung neuer Hautschutzmaßnahmen für Winter- und Bergsportler 

(Development of new topical protection measures for winter/mountain athletes), 

Annual General Assembly of the Austrian Association of Sports Physicians, 


3/2010 

• Endoskopie wird MIC (Endoscopy goes MIC), 2 nd Internet-Videoconference of the 

Society of Physicians in Vorarlberg with the Society of Physicians in Vienna, 

welcome remarks and moderation, 22.11.2006, Feldkirch and Vienna, Austria 

• Biologika – up date (Biologics – up date), Post-graduate Training Program for 

Physicians, 12.1.2007, Feldkirch, Austria 

• Allergien: Diagnose und neue Behandlungsmöglichkeiten für den Hausarzt (Allergies: 

Diagnosis and new treatment options for the family doctor), Annual Meeting of the 

Austrian Society of Family Doctors, 18.1.2007, Lech, Austria 

• Long-Term treatment strategies and safety of etanercept in the management of 

psoriasis and psoriatic arthritis. Series of Lectures (Gulf Lecture Tour), Wyeth 

Middle East and North Africa, presentations, grand rounds, round table discussions 

and Q&A sessions. 14.-22.2.2007; Dubai, United Arab Emirates, Kuwait City, Kuwait, 

Jeddah, Damman and Riyadh, Saudi Arabia 

• Diaklinik (Dermatological slide show) of the Department of Dermatology, Federal 

University Teaching Hospital of Feldkirch, for the Vorarlberg Medical Association 

of Dermatologists in Office, 2.3.2007, Feldkirch, Austria 

• MRSA – an increasing danger, Smith and Nephew Workshop at the 10 th Annual 

Meeting of the German Society for Wound Healing and Treatment, 9.3.2007, 

Berlin, Germany 

• Long-term treatment strategies and efficacy of Etanercept, Workshop at the Wyeth 

European Summit Progress and Promise, 16.3.2007, Munich, Germany 

• Der neue Vorarlberger Biomed-Cluster (The New Vorarlberg biomed-cluster), 

Opening Symposium of the new VIVIT Competence Center, chair/moderation and 

closing remarks, 22.3.2007,Dornbirn, Austria 

• Nanokristalline Silberwundauflagen und MRSA: Eine Lösung für ein zunehmendes 

Problem? (Nanocristalline silver dressings and MRSA: a solution to an increasing 

problem?), Symposium by Smith and Nephew Germany, 11.4.2007 Hamburg and 

30.5.2007 Dortmund, Germany 

• Nanokristalline Silberwundauflagen und MRSA: Eine Lösung für ein zunehmendes 

Problem? (Nanocristalline silver dressings and MRSA: a solution to an increasing 

problem?), 5 th Hygiene Days of Ulm, 18.4.2007, Ulm, Germany 

• Allergien: Diagnose und neue Behandlungsmöglichkeiten (Allergies: Diagnosis and 

new treatment options), Alk-Abello Symposium for the Vorarlberg Association of 

Family Doctors, 26.4.2007, Bregenz, Austria 

• Der Einfluß von topischem Tacrolimusauf die Epikutantestreaktion mit Nickel (The 

impact of Tacrolimus on the nickel patch test reaction), Astellas Lunch Symposium 

at the 44 th Annual Meeting of the German Dermatologic Society, 27.4.2007, 

Dresden, Germany. 

• Infection and resistant bacteria. 17 th Conference of the European Wound 

Management Association, 3.5.2007, Glasgow, UK 

21

3/2010 

• Außenarbeit und Hautschutz – DERM-OCC, das Programm (Out-door work and Skin 

protection – DERM-OCC the program), HSEQ Working Group Meeting of the VKW 

Vorarlberg, 8.5.2007, Bregenz, Austria 

• Mögliche Lösungen mit nanokristallinem Silber (Possible solutions with 

nanocrystalline silver), Smith & Nephew Satellite Symposium at the Annual 

Meeting of the German Initiative Chronic Wounds, 9.5.2007, Bremen, Germany 

• Out-door work as potential risk for melanoma, EADO Sister Society Symposium at 

the 17 th Annual EADV Congress, chair and lecture, 16.5.2007, Vienna, Austria 

• Hauttumore (Tumors of the skin), Post-graduate Training Program for Physicians. 


• Local MRSA management of acute and chronic wounds and wound solution @ 

Vorarlberg, 9 th Annual Meeting of the AWA and 1 st combined Annual Meeting of 

the AWA and the SAfW, 1.-2.6.2007, Bregenz, Austria 

• Sonne – Haut – Sport (Sun – Skin – Sports), Teaching Course for Sports 

Physicians at the 16 th Days of Physicians, 8.6.2007, Grado, Italy 

• Development and implementation of process oriented skin safety standards for the 

mineral oil industry: a pilot study, 2 nd World Congress on Work-related and 

Environmental Allergies, 13.6.2007, Weimar, Germany 

• The safe use of biologics and development of strategies for the management of 

psoriatic arthritis, Lecture and Workshop at the Wyeth Pacific and Asian 

Psoriasis Summit, 3.-4.7.2007, Seoul, Korea 

• Therapiealgorithmus für die Psoriasisarthritis aus der Sicht der Dermatologie 

(Therapeutic algorithm for psoriatic arthritis – the dermatology view), 5 th Abbott 

Scientific Forum Rheumatology and Dermatology, 15.9.2007, Vienna, Austria 

• Die Therapie des Herpes zoster – ein Expertenkonsensusstatement (The therapy of 

herpes zoster – an expert consensus statement), Menarini Symposia, 28.9. Zell am 

See und 4.10.2007 Dornbirn, Austria 

• DERM-OCC und UV Schutz für Außenarbeiter. Ein Präventions- und 

Sicherheitsprogramm für die Industrie (DERM-OCC and UV protection for out-door 

workers. A prevention and security concept for the industry), Guest Lecture at 

Turimed Headquarters, 9.10.2007, Wiellesen, Switzerland 

• Long-term treatment strategies and efficacy of etanercept, Wyeth Portugal 

Psoriasis Summit, 10.11.2007, Faro, Portugal 

• Debate: The MRSA guidelines are not enough Wound Symposium at the Annual 

VEITH Congress of the US Society of Vascular Surgeons, 14.11.2007, New York, 

USA 

• Das locale Management local infizierter Wunden (Local management of locally 

infected wounds), Lohmann und Rauscher Wound Symposium, 28.11.2007, 


• Die topische Behandlung von Basaliomen mit 5% Imiquimod (Treatment of basal cell 

carcinomas with 5% topical Imiquimod), MEDA Lunch Symposium at the Annual 

Meeting of the Austrian Society of Dermatology and Venerology, 1.12.2007, 


22

3/2010 

• Das atopische Ekzem (atopic eczema) und Qualitätszirkel – 1 Jahr Erfahrung mit der 

Gräsertablette (quality circle - 1 year experience with the grass pollen tablet) Annual 

Meeting of the Austrian Society of Family Doctors, 24.1.2008, Lech, Austria 

• Silberverbände und das Management chronischer Wunden (Silver dressings and the 

management of chronic wounds), Wound Symposium of the General Hospital 

Stuttgart, 27.2.08, Stuttgart, Germany 

• Psoriasis and Co-morbididies, up date psoriasis treatment and up date biologics. 2 nd 

International JeddahDerm Conference, 2.-5.3.08, Jeddah, Saudi-Arabia 

• Demonstrating the value of Etanercept therapy, Meet the Expert Session at the 

Wyeth European Summit Progress and Promise, 13.-15.3.2008, Madrid, Spain 

• Opportunities in psoriasis management, Best Practice Wyeth Europe and MENA 

Internal Marketing Meeting, 27.3.2008, Vienna, Austria 

• From Evidence to treatment – therapeutic algorithm for critically colonized/locally 

infected wounds. 10 th Annual Meeting of the AWA, 28.3. 2008, Vienna, Austria 

• What is new on Etanercept. Austrian Wyeth Scientific Forum Rheumatology and 

Dermatology, round table discussion, 12.4.2008, Irdning, Austria 

• Psoriasis: long-term disease, long term solutions, Series of Lectures (Lecture Tour) 

Wyeth Portugal, 15.-18.4.2008, Oporto, Coimbra and Lissbon, Portugal 

• Treatment of basal cell carcinoma with 5% topical Imiquimod, MEDA Lecture at the 

COSMODERM Symposium, 18.4.2008, Prag, Czech Republic 

• Die großen Erkrankungen in der Dermatologie, Neurodermitis, Schuppenflechte und 

der weiße Hautkrebs: Gibt es eine Hoffnung auf Heilung (The big diseases in 

dermatology, atopic eczema, psoriasis and white skin cancer: can we hope for a 

cure?), MINIMED Teaching Series. 23.4.2008, Wolfurt, Austria 

• Die Therapie des Herpes zoster – ein Expertenkonsensusstatement (The therapy of 

herpes zoster – an expert consensus statement), Menarini Symposium, 24.4.2008, 

Salzburg/Wals, Austria 

• Effect of continuous versus paused Etanercept therapy over 54 weeks for psoriasis 

patients and psoriasis: long-term disease, long-term solution and the Crystal study, 

pediatric psoriasis and the 318 trial, XVIII RADLA Congress and Wyeth RADLA 

Satellite Symposium and Wyeth Speakers Training, 2.-3.5.2008, Curitiba, Brasil 

• Die Behandlung local infizierter Wunden: Von der Evidence zum Therapiealgorithmus 

(Treatment of locally infected wounds: from evidence to a therapeutic algorithm), 

Lohmann & Rauscher Satellite Symposium at the Annual Meeting of the 

German Initiative Chronic Wounds, 8.5.2008, Bremen, Germany 

• Locally infected wounds – from evidence to a therapeutic algorithm, Lohmann & 

Rauscher Symposium at the 18 th Conference of the European Wound 

Management Association, 15.5.2008, Lisbon, Portugal 

• Optimizing the management of psoriasis with biologics, Wyeth Symposium at the 

Combined Annual Meeting of the Czech and Slovak Societies of Dermatology 

and Venereology, 6.6.2008, Bratislava, Slovak Republic 

23

3/2010 

• Die Behandlung local infizierter Wunden: Von der Evidence zum Therapiealgorithmus 


Lohmann & Rauscher Satellite Symposium at the Annual Conference of the 

German Society for the Treatment of Wounds, 14.6.2008, Koblenz, Germany 

• Die Wissenschaft hinter dem Hautschutz – wo wir stehen, wohin wir gehen (The 

science behind skin protection – where do we stay, where do we go), Round Table 

Discussion at the 9 th International Skin Protection Day, 18.6.2008, Krefeld, 

Germany 

• Psoriasis: Long-term disease – long-term solution, Wyeth Germany Internal Tertiary 

Meeting, 4.9.2008, Berlin, Germany 

• Psoriasis up date: Comorbidities and Biologics, Wyeth Optimus 

Dermatology/Rheumatology Meeting, 5.9.2008, Helsinki, Finland 

• Wie behandle ich Herpes zoster (How to treat herpes zoster), Menarini Pain 

Symposium, 27.9.2008, Pichl, Austria 

• Treatment of Psoriasis – up date, Wyeth Czech Dermatology Expert Meeting, 

30.9.2008, Prag, Czech Republic 

• Lokal infizierte Wunden - : Von der Evidence zum Therapiealgorithmus (Locally 

infected wounds - from evidence to a therapeutic algorithm), 40 th Annual 

Conference of the Austrian Society of Vascular Surgeons. 10.10.2008, Vienna, 

Austria 

• Etanercept: efficacy, dosing regimen and safety profile in psoriasis, Wyeth Lunch 

Symposium at the Annual Meeting of the Rumanian Society of Dermatology, 

17.10.2008, Sibiu, Romania 

• Lokal infizierte Wunden: Von der Evidence zum Therapiealgorithmus (Locally infected 

wounds - from evidence to a therapeutic algorithm), 7 th Vorarlberg Congress 

Nursing of Geriatric Patients, 29.10.2008, Nenzing, Austria 

• Broadening the clinical utility of Etanercept in psoriatic disease and etanercept: 

clinical trials and case studies, Lecture and Workshop at the 4 th Wyeth Psoriasis 

Summit of Middle East and North Africa, 4.-5.11.2008, Cairo, Egypt 

• Pädiatrische/juvenile Psoriasis (Pediatric/juvenile psoriasis), Wyeth Lunch 



• Etanercept – Dosis, Regime und Sicherheit (Etanercept – dosage, regimen and 

safety), Meeting of the Bavarian Medical Assotiation of Dermatologists, 

14.1.2009, Munich, Germany. 

• Psoriasis-co-morbidities, psoriasis-management of the disease and biologics-safety, 

1 st Wyeth MENA Etanercept Speakers Bureau, 18.-19.1.2009, Dubai, United Arab 

Emirates 

• Up date on psoriasis treatment, Hungarian Etanercept Expert Meeting, 5.2.2009, 

Budapest, Hungary 

• Raising the bar in psoriasis treatment, 1 st Bahrain Society of Dermatology 

Psoriasis Symposium, 27.2.2009, Bahrain City, Bahrain 

• Genieße die Sonne, aber richtig (Enjoy the sun, but do it the right way), Annual 

Meeting of the Nursing Association Tosters, 20.3.2009. Feldkirch, Austria 

24

3/2010 

• The Presta trial, the Crystal study and pediatric psoriasis, 1 st Wyeth South American 

Etanercept Speakers Bureau, 26.3.2009, Amsterdam, Netherlands 

• Clinical decision making: management algorithms, what to do and when? and 

biologics – patient eligibility and treatment choice, Work shop and Meet-the Expert- 

Session at the Wyeth European Summit Progress and Promise, 27.3.2009, 

Amsterdam, Netherlands. 

• Humira und die Psoriasisarthritis – Studienergebnisse (Humira and psoriatic arthritis – 

results from the studies), Austrian Abbott Expert Board Meeting, 18.4.2009, 


• Practical aspects in the treatment of psoriasis, Wyeth Satellite Symposium at the 

6 th EADV Spring Symposium, 24.4.2009, Bucharest, Rumania 

• Continuous versus intermittent therapy of psoriasis: what does your patient need? 

Wyeth Satellite Symposium at the 45 th Meeting of the German Dermatology 

Society, 4.4.2009, Dresden, Germany 

• Polihexanid – ein neuer vielversprechender Wirkstoff für die lokale anti-mikrobielle 

Therapie (Polihexanid – a new, promising compound for the local anti-microbial 

therapy), Lohmann & Rauscher Satellite Symposium at the Annual Meeting of 

the German Initiative Chronic Wounds, 6.5.2009, Bremen, Germany 

• The efficacy and safety of biologics in psoriasis, new data on Etanercept and clinical 

studies, Lecture and Workshop at the 5 th Wyeth Psoriasis Summit of Middle 

East and North Africa, 7.-8.5.2009, Beiruth, Lebanon 

• Sonne – Haut – Sport (Sun – Skin – Sports), Meeting of the Austrian Society 

Military Medicine, Section Vorarlberg, 11.5.2009, Bregenz, Austria 



therapy), Austrian Lohmann & Rauscher Educational Symposia and Workshops, 

3.5. Vienna, 28.5. Zell am See, 4.6.2009 Graz, 9.6.2009 Salzburg, Austria 

• Outdoor exposure and other occupational exposures as risk factors for NMSC, 

Symposium SY10 at the 7 th World Congress on Melanoma and 5 th Congress of 

the European Association of Dermato-Oncology, lecture and chair, 13.5.2009, 

Vienna, Austria. 

• Polihexanid – a promising compound for the treatment of locally infected wounds, 

Lohmann and Rauscher Satellite Symposium at the 19 th Conference of the 

European Wound Management Association, 21.5.2009, Helsinki, Finnland 

• Heuschnupfen und Asthma (Hey fever and Asthma), MINIMED Teaching Series, 

27.5.2009, Wolfurt, Austria 

• Polihexanid – a promising compound for the treatment of locally infected wounds. 

Lohmann and Rauscher Symposium for the Eastern European Countries, 

28.5.2009, Zell am See, Austria 

• Psoriasis disease burden and co-morbidities, case series, and Etanercept up date, 

North German Wyeth Cooperative Dermatology Rheumatology Symposium, 

lectures and chair, 12.-13.6.2009, Dierhagen, Germany 

• Guidelines for the treatment of locally infected wounds, 11 th Annual Meeting of the 

AWA and 2 nd combined Annual Meeting of AWA and SafW, lecture and multiple 

chairs, 19.-20.6.2009, Zurich, Switzerland 

25



therapy), Lohmann and Rauscher Satellite Symposium at the 11 th Annual 

Meeting of the AWA and 2 nd combined Annual Meeting of AWA and SafW, 

19.6.2009, Zurich, Switzerland 

3/2010 



therapy), Lohmann and Rauscher Satellite Symposium, 12 th Annual Meeting of 

the German Society for Treating Wounds, 25.6.2009, Kassel, Germany 

• Mikrobiologische Aspekte bei der Behandlung lokal infizierter Wunden mit Silber 

(Microbiological aspects in the treatment of locally infected wounds with silver) und 

Die Behandlung local infizierter Wunden: Von der Evidence zum Therapiealgorithmus 


Symposium Austrian Smith + Nephew Academy, 26.6.2009, Innsbruck, Austria 

• Etanercept clinical trials in psoriasis, Wyeth Global Dermatology Advisory Board, 

24.-25.7.2009, Paris France 

• Polihexanid – die Studienlage (Polihexanid – studies and trials), Internal Lohmann 

and Rauscher Marketing Meeting, 4.9.2009, Vienna, Austria 

• Cavilon – Vom Wundrandschutz zum Hautschutz (Cavilon – from wound edge 

protection to skin protection), 1 st Symposium of the Tyrolean Wound Plattform, 

18.9.2009, Alpbach, Austria 

• Psoriasis disease – insight out, Wyeth Media Academy at the at the 18 th Annual 

EADV Meeting, 8.10.2009, Berlin, Germany 

• Immunologic treatment in NMSC – Place in practice, Symposium W14 at the 18 th 

Annual EADV Meeting, 9.10.2009, Berlin, Germany 

• Infection Control: How to postpone deterioration in diabetic feet, Breakfast 

Symposium at the Ilegx Meeting, 14.5.2009, Munich, Germany 

• Polihexanid vs. silver wound dressings: interim results from a controlled, randomized, 

multicentric, prospective study, Activa Satellite Symposium at Wounds UK, 

9.11.09, Harrogate, UK 

• Die infizierte Wunde (Infected wounds), Starting Symposium “Wound Healing” at 

the Annual Meeting of the Austrian Society of Dermatology and Venerology, 


• Neues von Imiquimod bei der Behandliung aktinischer Keratosen (Imiquimod and 

actinic keratoses: news from an Austrian non-interventional study), Meda Lunch 



• Die infektgefährdete Wunde – klinische Sicht (Wounds at risk for infections – the 

clinical view), German/Swiss/Austrian Experts Meeting “The role of polihexanid 

for wounds at infection risk, 5.12.2009, Vienna, Austria 

• Suprasorb-X und Suprasorb-X + PHMB: Up-date, Lohmann und Rauscher Germany 

V2 Marketing- and Out-field Representatives Meeting, 15.1.2010, Hohenroda, 

Germany 

26

3/2010 

• 5 Jahre Etanercept: Rückblick, Status-Quo und Ausblick (5 years of Etanercept: Past, 

present, future), Austrian Wyeth/Pfizer Marketing Meeting, 16.1.2010, Vienna, Austria 

• Etanercept for the treatment of moderate to severe psoriasis, presentation, Pfizer 

Speakers Training, 3.2.2010, Madrid, Spain 

• The many faces of inflammatory disease, understanding the role of appropriate 

treatment and where do we go from here, presentation, workshop and round table 

discussion, Wyeth Media Academy and press conference, 4.2.2010, Madrid, Spain 

• Use of biologics for the long-term treatment of psoriasis and differentiation in clinical 

practice: the right therapy for your patient, Plenary and workshop, Wyeth European 

Summit Progress and Promise, 5.2.2010, Madrid, Spain 

• Etanercept for the treatment of moderate to severe psoriasis, presentation, Pfizer 

Speakers Training, 25.3.2010, Barcelona, Spain 



therapy), UK Wounds Expert Meeting on the value of Polihexanid for the treatment 

of wounds, 30.3.2010, London, UK 

� Consultant Work 

• Procter & Gamble Inc. (1998 - 2001): 

- Review of and answers to professional and consumer health-related product 

inquires in Austria, 1998 - 2000 

- Clearasil Complete: Assistance in the generation of scientific objectives and 

strategies - a marketing project to address Austrian dermatologists and GPs. 

Assistance in the development of the brochure "Life - Unsere Haut" (life – our 

skin) target group: consumers age 12 - 20) 

- SECRET - Preparation of a brochure for the European market with professional 

health care workers as target group. Elected by Procter & Gable as the single 

best approach for roll-out across Europe 

- Menopause and the skin - ProVital: Consultant work for the global unit of 

Procter & Gamble (GBU-EGHAM-UK) to develop strategies and scientific 

objectives for a world-wide marketing programme on the basis of the "Austrian 

gynecologist Model" (brochure, skin manual, scientific product profile) for Oil of 

Olaz 

- Charming - bath paper: evaluation and review of pre-marketing skin-safety 

studies 

• Health Consult Inc. - Center of Occupational Medicine and Medical Consulting 

(1996 – 2002): 

- Melanoma prevention program 

- Dermatological assistance for physicians in the field of occupational medicine 

• OMV – Austrian Mineral Oil Association: medical consultancy in form of cooperation 

projects - dermatology and occupational medicine, start 10/00-1/08 

• Brial GesmbH Global: strategic consultancy, 3/02-10/05 

27

• American Academy of Dermatology: Designated as formal observer for the 62 nd 

Annual Meeting, February 6 th – 11 th , 2004, Washington DC, USA 

3/2010 

• Smith + Nephew GmbH: consultancy, speakers bureau, investigator originated 

projects (IOPs), start 9/02- 

• Astellas Pharma Austria: consultancy, speakers bureau, start 5/03-11/08 

• Wyeth Global: consultancy, speakers bureau, start 9/03- 

• Sanova GesmbH Austria: consultancy, 2/04-10/06 

• Serono GesmbH Austria: consultancy, 9/04-1/05 

• Abott Inc. Austria: consultancy, start 8/05-10/08 

• Helbo Photodynamic Lasersystems International: developmental consultancy, 

IOPs, start 9/05- 

• Menarini GesmbH Austria: consultancy, speakers bureau, 10/05-11/08 

• ucb Pharma GesmbH Austria: consultancy, 2/06-11/07 

• 3M-Woundcare GmbH Austria: consultancy, speakers bureau, IOP, start 5/06- 

• Intendis GesmbH, Austria and Europe: consultancy, start 11/06- 

• Lohmann und Rauscher GmbH, Global: consultancy, speakers bureau, IOP, start 

9/07- 

• Meda Pharma GesmbH, Austria, consultancy, speakers bureau, IOP, start 9/07- 

• Turimed AG Schweiz (Arbeitsschutz): developmental consultancy, start 2/08- 

• ENJO GesmbH Global: developmental consultancy, IOP, start 6/08- 

• Pantec Biotechnologies AG Global, developmental consultancy, start 7/08- 

• Actelion Pharmaceuticals, Austria, consultancy, start 8/08- 

• Schülke und Mair GesmbH, Global, consultancy, IOP, start 12/08- 

• AB-consult GesmbH Austria for Galderma GesmbH: consultancy, start 2/09- 

� Original articles (peer-reviewed) 

• R. KOFLER, D.J. NOONAN, R. STROHAL, R.S. BALDERAS, N.P.H. MOLLER, F.J 

DIXON and A.N. THEOFILOPOULOS. Molecular analysis of the murine lupus 

associated anti-self response: Involvement of a large number of heavy and light chain 

variable region genes. Eur. J. lmmunol. (1987), 17:91-95 

• G. KRÖMER, R. FÄSSLER, R. STROHAL, G. WICK and R. KOFLER. Evidence for a 

new murine immunglobuline heavy chain variable region gene family. 

Immunol.lnvestigations. (1986), 16:107-116 

• R. STROHAL, G. KRÖMER, G. WICK and R. KOFLER. Complete variable region 

sequence of a non-functionally rearranged kappa light chain transcribed in the nonsecretor 

P3-X63-Ag8.653 myeloma cell line. Nucleic Acid Research. (1987), 15:2771 

• R. KOFLER, M.A. DUCHOSAL, M.E. JOHNSON, M.T. AGUADO, R. STROHAL, 

G.KRÖMER and R. FÄSSLER. The genetic origin of murine lupus-associated 

autoantibodies. Immunol. Letters. (1987), 16:265-272 

• R. KOFLER, R. STROHAL, R.S. BALDERAS, M.E. JOHNSON, D.J. NOONAN, M.A. 

DUCHOSAL, F .J. DIXON and A.N. THEOFILOPOULOS. Ig germline gene 

organization and Ig genes expressed in anti-DNA autoantibodies from lupus mice. 

J.Clin.lnvest. (1988), 82:852-860 

28

• R. STROHAL, G. KROEMER, H. WOLF, G. WICK and R. KOFLER. Molecular 

analysis of the Lupus-associated anti-self immune response. Wi.Kli.Wo. (1988), 

23:753-760 

3/2010 

• R. STROHAL, A. HELMBERG, G. KROEMER and R. KOFLER. Mouse Vk gene 

classification by nucleic acid sequence similarity. Lmmunogenetics. (1989), 30:475- 

493 

• R. STROHAL, R. GILLITZER, E. ZONZITS and G. STINGL. Localized vs. generalized 

pyogenic granuloma: A clinicopathological study. Arch. Dermatol. (1991), 

127:856-861 

• W. ABERER and R. STROHAL. Homeopathic preparations - severe adverse effects, 

unproven benefits. Dermatologica. (1991), 182:253, 

• ELBE, O. KILGUS, R. STROHAL, E. PA YER, S. SCHREIBER and G. STINGL. Fetal 

skin: a site of dentritic epidermal T Cell developement. J. lmmunol. (1992), 149:1694- 

1701 

• R. STROHAL and E. DIEM. Chronic but progredient perianal ulcers. Arch. Dermatol. 

(1992), 128:1115-1120 

• E. PAYER, R. STROHAL, R. KUTIL, A. ELBE and G. STINGL. Demonstration of a 

CD3+ Iymphocyte subset in the epidermis of athymic nude mice: evidence for TCR - 

diversity. J. Immunol. (1992), 149:413-420 

• R. STROHAL, R. GILLITZER, E. ZONZITS and G. STINGL. Generalized pyogenic 

granuloma. Dermatoloqy Digest. (1992), 2:6-7 

• R. STROHAL, K. RAPPERSBERGER, H. PEHAMBERGER and K. WOLFF. Nonbullous 

pemphigoid: Prodrome of bullous pemphigoid or a distinct pemphigoid 

variant? J. Am. Acad. Dermatol. (1993), 29:293-299 

• W. ABERER, H. HOLUB, R. STROHAL and G. SLAVICEK. Palladium in dental alloys 

- the allergists responsibility to warn? Contact Dermatitis. (1993), 28:163-165 

• O. KILGUS, E. PA YER, S. SCHREIBER, A. ELBE, R. STROHAL and G. STINGL. Invivo 

cytokine expression in normal and perturbed murine skin - analysis by 

competitive quantitative polymerase chain reaction. J. lnvest. Dermatol. (1993), 

100:674-680 

• R. STROHAL, L. PAUCZ, H. PEHAMBERGER and G. STINGL. T -Cell receptor 

repertoire of Iymphocytes infiltrating cutaneous melanoma is predominated by Vα 

specificities present in normal human skin. Cancer Research. (1994), 54:4734-4739 

• R. STROHAL, K. MARBERGER, H. PEHAMBERGER and G. STINGL. 

Immunhistological analysis of anti-melanoma host responses. Arch. Derm. Res. 

(1994), 287:28-35 

• F. TRAUTINGER, C. JANTSCHITSCH, R. STROHAL, M. POURMOJIB and I. 

KINDAS-MÜGGE. Mispriming and PCR amplification of hsp27. Cell Stress & 

Chaperones (1998), 2:276-277 

• R. STROHAL, CH. BRNA, U. MOSSBACHER, G. FISCHER, H. PEHAMBERGER 

and G. STINGL. First comparative delineation of the T -Cell receptor repertoire in 

primary and multiple subsequent/coexisting metastatic melanoma sites. J. Invest. 

Dermatol. (1998), 111:1085-1091. 

• R. STROHAL, E. TSCHACHLER, S. BREYER, A. UTHMAN, I. SIMONITSCH, S. 

TRATTNIG, W. SCHEITHAUER, G. STINGL and G.V. KORNEK. Reactivation of 

29

3/2010 

Behcet's disease in the course of a multicentric HHV8-positive Castleman's disease: 

long-term complete remission by a combined chemo/radiation and Interferon-α 

therapy regimen. Brit. J. Haematol. (1998), 103:788-790. 

• R. STROHAL and G. STINGL. What is the best way to define the anti-melanocyte Tcell 

repertoire? J. Invest. Dermatol. (1999), 113:286-288. 

• R. STROHAL, R. MOSSER, H. KITTLER, K. WOLFF, B. JANSEN, C. BRNA, G. 

STINGL, and H. PEHAMBERGER. Comparative PCR analyses of MART -1/Melan-A 

and tyrosinase mRNA expression in peripheral blood of stage I-IV melanoma 

patients. Melanoma Research, (2001), 11: 543-548. 

• D. WINTER, E. FIEBIGER, P. MERANER, H. AUER, CH. BRNA, R. STROHAL, F. 

TRAUTINGER, R. KNOBLER, G.F. FISCHER, G. STINGL, and D. MAURER. 

Definition of T Cell receptor epitopes für cytotoxic T -Iymphocyte-mediated attack of 

cutaneous lymphoma. J. Immunol., (2003), 171: 2714-2724 

• C. SCHIESSL, C. WOLBER and R. STROHAL. Reproducibility of patch tests: 

Comparison of identical test allergens from different commercial sources. Contact 

Dermatitis. (2004), 50:27-30. 

• C. SCHIESSL and R. STROHAL. Reply: Reproducibility of patch tests. Contact 

Dermatitis. (2004), 51:45-46 

• W. RHOMBERG, H. EITER, F. BOEHLER, CH. SAELY and R. STROHAL. Combined 

Razoxane and Radiotherapy for Melanoma Brain Metastases: a retrospective study. 

Journal of Neuro-Oncology. (2005), 74:295-299 

• R. STROHAL, M. SCHELLING, M. TAKACS, W. JUREKA, U. GRUBER AND F. 

OFFNER. Nanocrystalline silver dressings as an efficient anti-MRSA barrier: a new 

solution to an increasing problem. Journal of Hospital Infection. (2005), 60:226-230 

• W.H. BÖHNKE, R.A. BRASIE, J. BARKER, S. CHIMENTI, E. DAUDÉN, M. DE RIE, 

L. DUBERTRET, A. GIANETTI, A. KATSAMBAS, K. KRAGBALLE, J.M. NAEYAERT, 

J.P. ORTONNE, J. PEYRI, J.C. PRINZ, J.H. SAURAT, R. STROHAL, P. VAN DER 

KERKHOF and W. STERRY. Recommendations for the use of etanercept in 

psoriasis: a European Dermatology Expert group consensus. Journal of the European 

Academy of Dermatology. (2006), 20: 988-998 

• C. SCHIESSL, C. WOLBER, M. TAUBER, F. OFFNER AND R. STROHAL. 

Treatment of all basal cell carcinoma variants including large and high risk lesions 

with 5% imiquimod cream: histological and clinical changes, outcome, follow up. 

Journal of Drugs in Dermatology. (2007), 6:507-513 

• G. STARY, CH. BANGERT, M. TAUBER, R. STROHAL, T. KOPP and G. STINGL. 

Tumoricidal activity of T2R7/8-activated inflammatory dendritic cells. J. Exp. Med. 

(2007), 204:1441-1451 

• J.P. ORTONNE, CH. GRIFFITHS, E. DAUDEN, R. STROHAL, D. ROBERTSON, R. 

PEDERSEN, CH. MOLTA and B. FREUNDLICH. The efficacy and safety of continous 

versus paused Etanercept treatment in patients with moderate to severe psoriasis 

over 54 weeks: The CRYSTEL study. Expert Rev. Dermatol. (2008), 3(6): 657-665 

30

3/2010 

• J. DISSEMOND, T. EBERLEIN, V. GERBER, A. KRAMER, G. RIEPE, R. STROHAL, 

A. VASEL-BIERGANS. Praxisorientierte Expertenempfehlung zur Behandlung 

kritisch-kolonisierter und lokal infizierter Wunden mit Polihexanid (Praxis-oriented 

expert consensus statement for the therapy of critically colonized and locally infected 

wounds with Polihexanid). Zeitschrift für Wundheilung. (2009), 1:20-26 

• F. GUIBAL, L. IVERSEN, F. NESTLE, L. PUIG and R. STROHAL. Identifying the 

biologic closest to the ideal to treat chronic plaque psoriasis: using multi-attribute 

decision modelling as a decision-support aid. Current Medical Research & Opinion 

(2009), 25: 2835-2843 

� Original articles (invitation and/or non peer-reviewed) 

• CH. WOLF, G. MÄNNER, S. MEGHDADI, A. MICHITSCH und R. STROHAL. Fieber 

durch inhalative Noxen: Seltene Ursachen (Fever due to inhaled toxins: rare cases). 

Atemw.Lunqenkrkh. (1995), 21 :S70-S71 (1. Suppl.) 

• R. STROHAL. Dermatologie und Venerologie in Vorarlberg, Jartros Dermatologie, 

(2002) 6:28 

• A. BREUß, C. WOLBER, J. ROTHMUND and R. STROHAL. Mykobakteriose mit 

atypischem Verlauf? (Mycobakteriosis with atypical course?) Pneumologisch. (2003), 

4:22-23 

• CAROLA WOLBER; FELIX OFFNER AND ROBERT STROHAL. Therapieresistente 

zentrofaziale Schwellung im Jugendalter (Therapy-resistant zentrofacial swelling in a 

juvenile patient). Jartros Dermatologie, (2004), 1:42-43 

• NIKOLE SPEISER-RANKINE, WERNER UNTERBERGER, RUDOLF TAIBL, GABI 

PAYER-NEUNDLINGER; MARTINA MITTLBÖCK AND ROBERT STROHAL. 

Development and implementation of process-oriented skin safety standards for the 

mineral oil industry – a pilot study. Society of Petrol Engineers Journal, (2006), 

2: 853-863 

• ROBERT STROHAL, MARC SCHELLING, MICHAEL TAKACS, WOLFGANG 

JUREKA, ULRIKE GRUBER AND FELIX OFFNER. Opatrunki z nanokryztalami 

srebra jako skuteczna bariera przeciwko szczepom MRSA: nowy sposób na 

rozwiązanie rosnącego problemu. Leczenie Ran. (2006), 3(S2): S29-S33, 2006 

(reprint in Polish from the Journal of Hospital Infection, (2005), 60:226-230, 

Nanocrystalline silver dressings as an efficient anti-MRSA barrier: a new solution to 

an increasing problem) 

• CH. EBNER, W. ABERER, W. EMMINGER, T. HAWRANEK, F. HORAK, R. 

JARISCH, G. KLEIN, G. MODER, P. OSTERTAG, W. POHL, N. REIDER; R. 

STROHAL, S. WÖHRL. Die Tabletten basierte Immuntherapie der Graspollenallergie 

(Grass pollen allergies – Tablet based Immunotherapy). Journal of the Austrian 

Medical Association. Supplement, 2/07 

• R. STROHAL. DIE ABTEILUNG FÜR DERMATOLOGIE UND VENEROLOGIE AM 

LKH FELDKIRCH, UNIVERSITÄRES LEHRSPITAL – EINE PRÄSENTATION (The 

Department of Dermatology and Venerology at the Federal University Teaching 

Hospital in Feldkirch, Austria – a presentation). Journal of the German Society of 

Dermatology. (2007), 5:542 

31

3/2010 

• R. STROHAL. Allergien – der gepflegte Patient und die Pflegenden (Allergies – The 

nursed patient and the nurse). DaSein – Journal for Home Nursing. (2007), 2: 5-7 

• H. HÖNIGSMANN, W. ABERER, J. AUBÖCK, P. FRITSCH, H. HINTNER, W. 

JURECKA, G. KLEIN, P. MISCHER, R. MÜLLEGGER, W. PACHINGER, H. 

PEHAMBERGER, K. RAPPERSBERGER, G. STINGL, R. STROHAL, A. TANEW- 

ILITSCHEW, F. TRAUTINGER, B. VOLC-PLATZER, and P. WOLF. Der Stellenwert 

of Psorcutan-beta in der Behandlung der moderaten Psoriasis (The position of 

Psorcutan-beta in the therapy of moderate psoriasis). Experts consensus statement. 

Journal of the Austrian Medical Association. Supplement, 4/07 

• R. STROHAL. Etanercept - update. Hautnah. (2007), 3:15 

� Books, Bock Chapters and Reviews 

• G. KRÖMER, R. STROHAL, R. FÄSSLER, G. WICK, D.J. NOONAN, F.J. DIXON, 

A.N. THEOFILOPOULOS and R. KOFLER. Cloning and sequencing of murine lupusassociated 

autoantibody genes. In: The Influence of New Technology and Medical 

Practice. J.P.Paul, Ed. Macmillan Publishers Ltd., London (1986), 225-248 

• R. STROHAL, H. WOLF and R. KOFLER. Molekulargenetische Analyse der 

Autoantikörper-Produktion bei systemischem lupus erythematodes (Molecular genetic 

analysis of the autoantobody production by systemic lupus erythematosus). Extracta 

Derm. (1989), 3:156-157 

• G. STINGL, A. ELBE, E. PAYER, O. KILGUS, R. STROHAL and S. SCHREIBER. 

The role of fetal epithelial tissues in the maturation/differentiation of bone marrowderived 

precursors into dendritic epidermal T -cells (DETC) of the mouse. ln: Current 

Topics in Microbiology and Immunology. Springer Verlag Berlin, Heidelberg (1991), 

173:269-277 

• R. STROHAL. Localized vs generalized pyogenic granuloma. Clinical Digest Series. 

(1992), 12:808-809 

• A. MICHITSCH, R. STROHAL, W. OSTERODE, CH. WOLF und B. ORTEL. Ein Fall 

von Plumboporphyrie als Beispiel für die Grenzwertproblematik in der Arbeitsmedizin 

(A case of plumbo-porphyria as example for the problem of exposure limits in 

occupational medicine). In: Gentoxische Substanzen in der Arbeitswelt, Editor: E. 

Baumgartner; Austrian Society of Industrial Medicine; Verlag Wilhelm Maudrich, 

Wien, München (1995), 20-22 

• G. KOFLER, I. MOSCHEN, E. TSCHACHLER und R. STROHAL. Die Bedeutung von 

HIV in der Zahn-, Mund- und Kieferheilkunde: Ein virologisches, epidemiologisches 

und klinisches Update mit besonderer Berücksichtigung der HIV Infektionsprophylaxe 

und postexpositioneller Prävention (The role of HIV for the dentist I.). Stomatologie. 

(1997), 94:345-362 and Deutsche Zahnärztliche Zeitschrift. (1997), 52:586-596 

• G. KOFLER, I. MOSCHEN, E. TSCHACHLER und R. STROHAL. Die Bedeutung von 

HIV in der Zahn-, Mund- und Kieferheilkunde: Ein virologisches, epidemiologisches 

und klinisches Update (The role of HIV for the dentist II.). Schweizer Monatsschrift für 

Zahnmedizin. (1997), 107:1-9 

• R. STROHAL. Melanom Antigene. Onkoloqisch - Aktuelles für die Praxis. (1998), 

1:12-14 

32

3/2010 

• J. GRAY AND ROBERT STROHAL. Die Haut im Rahmen des Peri/post 

menopausalen Symptomenkomplexes: Eine kosmetische Herausforderung (The . 

menopausal skin – a cosmetic challange). Procter & Gamble GBU, EGHAM, London 

(2000) 

• R. STROHAL. Wieviel Wirkkosmetik braucht der Mensch? ((How much cosmetics 

needs a human being?). In: HAGE III - Wohin geht die kosmetische Industrie im 

neuen Millenium? IMUG Hannover (2001), 12-16 

• SCHNEEBERGER, R. STROHAL and G. STINGL. Das maligne Melanom. In: 

Klinische Onkologie, Editoren: H. Huber, W. Hiddemann, C.R. Bartram Springer 

Verlag Berlin, Heidelberg (2003), chapter 65:1553-1602 

• R. STROHAL. Basal cell carcinoma, invited review for the state of the art oncology 

(START) project by the Organizations of European Cancer Institutes, (2009), at the 

web site: http://www.startoncology.net/site/ 

� Other Publications/Certificates 

• Christian WEINBERGER AND ROBERT STROHAL. SECRET - Produktmonographie. 

Procter & Gamble Austria, Medizinisch-Wissenschaftliche Abteilung, Wien (1999) 

• The Year 2000 Monitoring Panel of external experts (ROBERT STROHAL - 

RAPPORTEUR, MIRIAM WILEY - RAPPORTEUR, JOHN DAVISON-RAPPORTEUR, 

CORNELIS DE WINTER, JYRKI LIESIVUORI, HELEN SAVAKI, FRIEDRICH 

WEISSBACH, und DANIEL THOMAS - CHAIRMAN). 2000 Annual monitoring report 

on the RTD activities conducted under the European Commission "Quality of life and 

management of living resources" program. Office for official publications of the 

European Communities, Luxembourg (2001) 

• K. WOLFF, ....., R. STROHAL, ...., B. VOLC-PLATZER. Alefacept – ein neuer 

immunmodulierender Therapieansatz in der Behandlung der Psoriasis (Alefacept – a 

new immunomodulating approach for the treatment of psoriasis). Experts consensus 

statement. Update. (2003), 14: 1-14 

• P. FRITSCH, ....., R. STROHAL, ...., B. VOLC-PLATZER. Stellenwert von 

Tacrolimus-Salbe (Protopic) in der Behandlung der atopischen Dermatitis (The role of 

topical Tacrolimus in the treatment of atopic eczema). Experts consensus statement. 

Update. (2004), 31:1-16 

• G. STINGL, R. STROHAL, ...., W.F. STERRY...., B. VOLC-PLATZER. Stellenwert 

von Etanercept in der Therapie der Psoriasis und Psoriasisarthritis (The role of 

Etanercept in the treatment of psoriasis and psoriatic arthritis). Experts consensus 

statement. Update. (2004), 41:1-19 

• G. STINGL, W. ABERER, ...., R. STROHAL...., K. WOLFF. Stellenwert von 

Efalizumab in der Behandlung der Psoriasis (The role of Efalizumab in the treatment 

of psoriasis). Experts consensus statement. Update. (2005), 21:1-20 

• W. ABERER, P. FRITSCH, HJ. RAUCH, G.STINGL and R. STROHAL. 

Positionspapier Behandlung der Psoriasis mit Biologika (Positioning paper for the 

treatment of psoriasis with biologics. Update. (2006), 1: 1-11 

• G. STINGL, A. REYNOLDS, S. CHIMENTI and R. STROHAL. Etanercept: Die 

Zukunft der Psoriasistherapie (Etanercept: The future of the psoriasis therapy). 

Advisory Board Report Wyeth Austria. (2006), 1:1-6 

33

3/2010 

• P. FRITSCH, H. PEHAMBERGER, K. RAPPERSBERGER, R. STROHAL and H.J. 

RAUCH. Algorithmus zur Kassenvergütung von Biologika bei der Behandlung von 

Psoriasis und Psoriasisarthritis in Österreich (Algorithm for the reimbursement of 

biologics in the treatment of psoriasis and psoriatic arthritis in Austria). 

http://www.oegdv.at/, 11/06 

• R. STROHAL, H.J. RAUCH, W. HEROLD and THE AUSTRIAN WORKING GROUP 

“BIOLOGICS IN DERMATOLOGY”. Die klinischen Zeichen der Psoriasisarthritis 

(Clinical signs of psoriathic arthritis). Flyer for all Austrian dermatologists in private 

office. 11/06 

• E. REBHANDL, M.E. BRETTLECKER, W. EMMINGER, G. HIRSCHBERGER, R. 

HOFFMANN-DORNINGER, G. KAMENSKI, B. MIRTL, P. OSTERTAG, P. PICHLER, 

E. SCHAMBERGER, K. SCHWEITZER, R. STROHAL. Diagnostics and therapy of 

allergies in the general practitioner’s office. Consensus Statement of the ÖGAM 

(Austrian Society of Family Doctors, a member of the WONCA). 12/06 

• S. HUBER and R. STROHAL. Four Case reports psoriasis and psoriatic arthritis on 2 

educational CDs for the best use of Etanercept in the treatment of psoriasis and 

psoriatic arthritis. Introduction CD-2 and 4 Case reports. An Educational Project by 

Wyeth Global. 3/07 

• S. HUBER and R. STROHAL. Psoriasis with psoriatic arthritis – an educational case 

report. Physicians education series at www.netdoctor.at, 3/07. 

• N. SONNBICHLER and R.STROHAL. Recommendation guidelines for fungal 

infections. Apotheker Krone. (2007), 8/27:14-15, up-date (2009), 11:16-19 

• R. STROHAL. Therapy (of herpes zoster) urgently needed. Interview. hautnah. 

(2007), 6/2:28 

• R. STROHAL. Sun-protection for children. Interview. Pediatrics and Pediology. (2007) 

2:8-11 

• M. BINDER, W. GRANINGER, R. KUNSTFELD, R. LIKAR, H. LUDWIG, G. MAYER, 

R. MÜLLEGGER, R. STROHAL. Brivudin, Mevir ® , in der Therapie des Herpes zoster 

(Brivudin, Mevir ® , in the Treatment of herpes zoster). Experts consensus statement. 

Focused Publishing. (2007), 10:1-4 

• R. STROHAL. Cavilon TM reizfreier Hautschutz (no sting barrier film) und Cavilon TM 

Langzeit Hautschutzcreme (durable barrier cream) im Management chronischer 

Wunden (in the management of chronic wounds): A medical application certificate for 

their reimbursement by the Austrian Association of Heath Care Insurances 

(Hauptverband der Versicherungsträger). 10/07, reimbursement since 1/09 

• R. STROHAL. Clobex ® 0,5% Shampoo für die Behandlung der moderaten und 

schweren Kopfhautpsoriasis (Clobex ® 0.5% shampoo for the treatment of moderate 

to severe scalp psoriasis): A medical application certificate for their reimbursement by 

the Austrian Association of Heath Care Insurances. 8/09 

• M. HIRSCL, M. BRODMANN, F. KARLHOFER, G. KLEIN, B. LEEB, R. STROHAL, F. 

TRAUTINGER, B. VOLC-PLATZER. Therapieempfehlung für Sklerodermieassoziierte 

digitale Ulzerationen (Recommended therapeutic modalities for 

sclerodermic ulcerations). Interdisciplinary Consensus Statement, Update. (2009), 26: 

1-16 

34

� Community Relations and Media Work 

3/2010 

• Sun without remorse awareness day. Initiative by the Austrian Society of 

Dermatology and Venerology together with the Austrian Cancer AID 

Organisation, start 5/02- 

Annual program for the province of Vorarlberg by the Department of Dermatology and 

the dermatologists in private office: press conference, visitation of industrial 

companies, teaching day for primary school children, free evaluation of moles at the 

Dept. of Dermatology, Federal University Teaching Hospital of Feldkirch, mole-watch 

at the public bath Felsenau 

• Radio Arabella: 

- Melanoma prevention and the sun awareness day, interview, 7.5.2003 

• Austrian Broadcast Radio – ORF Radio Vorarlberg: 

- Sun without remorse, 60 min. hotline (Aktuelles Thema), 4.4.2002 

- Been and wasp venom allergies, interview, news of the day, 14.5.2003 

- Sun without remorse awareness day, report, news of the day, 19.5.2003 

- Sexually transmitted diseases, report, 18.7.2003 

- Sun without remorse awareness day, report news of the day, 25.5.2004 

- Sun without remorse, 60 min. hotline, 27.5.2004 

- Feet-associated fungal infections, Lake Konstanz magazine , 28.2.2005 

- Sun and the skin, 60 min. hotline, 24.5.2005 

- Concerted action at the Felsenau, report, news of the day, 2.7.2005 

- Cold weather and the skin, 60 min. hotline, 11.1.2006 

- Botox and the dream of eternal youth, 60 min. hotline, 27.3.2006 

- sun and skin cancer, 60 min. Hotline, 15.5.2006 

- Skin cancer check at the public bath Felsenau, report, morning news, 7.6.2006 

- Hot days and the skin, report, morning news, 20.7.2006 

- The skin – an active coat of the soul and the body, 60 min. hotline, 4.6.2007 

- Sun and skin cancer, 60 min. hotline, 23.6.2008 

- Sun beds and the risk of skin cancer, report, daily news, 31.7.2009 

• Austrian Broadcast Radio – Ö1: 

- Silver as potent anti-microbial agent, report series: world of science, 20.12.2004 

• German South-West Radio (Südwest-Funk): 

- Announcement of the Lake Konstanz Allergy Symposium, interview, 10.11.2006 

- The plant Bärenklau and the danger of phototoxic reactions, report, breakfast 

news, 23.5.2006 

• Antenne Vorarlberg Radio: 

- Announcement of the Lake Konstanz Allergy Symposium, interview, 

10.11.2006 

• Radio Antenne Vienna: 

- What to do against sweating, report, morning news and drive time, 5.8.2003 

35

• Austrian Broadcast Television – Section Vorarlberg (ORF Vorarlberg heute): 

- General dermatology, report with interview, 3.3.2002 

- Increasing allergies, Report, report with interview, 24.4.2002 

- Melanoma prevention, report and studio discussion, 6.5.2002 

- Sun without remorse awareness day, report, , May 19, 2003 

- DERM-OCC – the project, report, 17.9.2003 

- Dangers of the sun in the mountains, report, 17.3.2004 

- Sun allergies, report, 2.4.2004 

- Sun without remorse awareness day, report, 26.5.2004 


- Concerted action at the public bath Felsenau, report and interview, 2.7.2005 

- Holistic wound management – the 1 st annual congress of the AWA and the 

SWFA in Bregenz, report and interview, 1.6.2007 


- New treatment options for allergies (the 2 nd Lake Konstanz Symposium: New 

Trends in Allergology), report and interview, 15.11.2008 

- Sun without remorse awareness day, report and interview, 28.5.2009 

• Sat-1/Austrian Television Window: 

- Biologics for psoriasis, report and interview, series health today, 27.10.2004 

3/2010 

• BBC-News online 

- Silver dressings to fight MRSA, (http://news.bbc.co.uk/1/hi/health/4172207.stm), 

18.1.2005 

• APA-News International online referring to 

- Silver dressings to fight MRSA, (http://news.bbc.co.uk/1/hi/health/4172207.stm), 

18.1.2005 

• APA-News Austria online as published in 

- How much sun screen do you need? 16.4.2007 

(http://www.oe24.at/zeitung/gesund/article 125301.ece) 

(http://wcm.krone.at/krone/S32/object_id_66847/hxcms/) 

(http://www.kleine.at/freizeit/aktivwellness/gesundheit/404051/index.do) 

(http://www.kurier.at/nachrichten/gesundheit/69761.php) 

(http://www.news.tele2internet.at/index.phtml/article/2825716?1176722817) 

• Austrian Broadcast Television online – www.orf.at 

- Sun and the skin, 60 minutes Chat, 24.5.2005 

- Sun and the skin, 60 minutes Chat, 23.6.2008 

• Vorarlberg online live – live.vol.at 

- 12 questions regarding the sun, 10.5.2008 

(http://www.vol.at/news/tp:vol:vorarlberg/artikel/vorsicht-sonnenbrandgefahr/cn/news- 

20080510-09064474) 

• Vorarlberger Nachrichten: 

- Strong increase in the incidence of atopic dermatitis – new therapeutic options, 

report, headline news, 25.9.2002 

36

3/2010 

- General dermatology, ask your specialist on the phone (1 hour), 10.10.2002 

- Hay fever - new therapeutic options, report, 18.4.2003 

- Melanoma prevention awareness day, multiple reports, 22.4., 24.4., 25.4., 28.4. 

15.5. and 19.5.2003 

- Sun and skin, sk your specialist on the phone (1 hour), 25.4.2003 

- Melanoma prevention awareness day, report, 26.5.2003 

- Sun and skin, ask your specialist on the phone (1 hour), 21.6.2004 

- Dermatological problems of the summer, interview, 23.6.2004 

- Skin and signs of internal diseases, report, 4.3.2005 

- Allergies and atopic eczema, ask your specialist on the phone (1 hour), 

announcement and reports 19.3., 22.3. and 24.3.2005 

- Let your spots be checked, interview, 26/27.5.2005 

- Progress on the track, report, 3.6.2005 

- „Safer” sun for those, who love the sun, interview, 24.6.2005 

- Mole check at the public bath Felsenau, report, 4.7.2005 

- The dangers of dry cold, report, 29.11.2005 

- Red cheeks might be dangerous, report, 31.12.2005 

- The early fight against the sun, report, 9.2.2006 

- Sun and skin cancer, multiple reports, 25.5. and 27.5.2006 

- Sun and skin, ask your specialist on the phone (1 hour), 29.5.2006 

- MINIMED Lecture Series: The skin – a specific coat for the body and the soul, 

announcing report, 3.6. and 6.6.2006 

- Awareness action “sun:watch” at three public baths in Vorarlberg (Bludenz, 

Feldkirch, Bregenz), report, 9.6.2006 

- MINIMED Lecture Series: The skin – a specific coat for the body and soul, 

report from the lecture evening, 10.6.2006 

- Can you eat beauty?, report, 13.9.2006 

- The new gras pollen vaccine tablet is a hope for allergy patients, report, 

11.11.2006 

- Physician and scientist, portrait series ”people from Vorarlberg about we speak”, 

13.112006 

- Smoking goes under and into the skin, report (as part of the series: how to 

become a non-smoker in 10 steps), 30.11.2006 

- Allergies are often under-diagnosed, section Healthy-Check, 27.1.2007 

- No chance for skin cancer, report, 3/4.3.2007 

- That the sun stays your friend, report, 6.4.2007 

- Burning dangerous for sportily active people, report, 19.4.2007 

- No fear of the sun, report, 5/6.5.2007 

- Treating chronic wounds the right way, report, 29.5.2007 

- Mosquitoes and bees – a potential danger, 4.7.2007 

- A small sting with large consequences, report, section health, 18/19.8.2007 

37

- UV-exposure and vitamin-D production, report, section health, 25/26.8.2007 

- Silk for the sensitive skin, report, section health, 27/28.9.2007 

3/2010 

- The fast Immunotherapy against allergies, report, section health, 26/27.1.2008 

- MINIMED Lecture Series: The big diseases of the skin – Is there a cure in 

sight?, announcing report, 19/20.4.2008 

- Ointment removes skin cancer, report about the MINIMED lecture, 

26/27.4.2008. 

- Mosquito plague in Vorarlberg, report, 9/10.8.2008 

- They lead with a good example: the skin protection program in the hospitals of 

Vorarlberg, report, 16/17.5.2009 

- MINIMED Lecture Series: A real sniffing pain – hey fever and asthma, 

announcing report, 23/24.5. 2009 

- Pollen like it hot and humid, report, 25.5.2009 

- Hey fever and asthma. report about the MINIMED lecture, 30/31.5.2009 

- Allergies, sun burn and other dermatological problems of the summer, ask your 

specialist on the phone (1 hour), 2.6.2009 

- Now is the time to treat pollinosis, report, 24.-25.12.2009 

• Der Standard: 

- Psoriasis and the therapy with biologics, report, StandardMed, 14.8.2006 

• Der Kurier: 

- Medical honey for chronic wounds, report, 25.12.2008 

• Liechtensteiner Vaterland: 

- Itching to the edge. report, 21.7.2007 

• Wann und Wo weekly: 


• Das kleine Blatt: 



• Jartros Dermatologie: 

- Argentum ante portas, report, (2003), 3:16 

• Forum Gesundheit: 

- Dermatological problems with the beard, report, (2003), 4:23 

- Thermoregulation (2007), 3:29 

• Hautnah der Ärztewoche: 

- Study to prevent relapses in atopic eczema, report, (2005), 4:27 

• Dermatology Times USA: 

- Out-door work as potential risk for melanoma, report, 5/05 

• Feldkircher Anzeiger 

- Sun without remorse – the 7 sun rules, interview, 20.5.2005 

38


• Heimat Bregenz 

- To treat chronic wounds the right way, report, 29.5.2007 

• Echo Gesundheit und Leben 

- To treat chronic wounds the right way, report, 29.5.2007 

• NEUE Vorarlberger Tageszeitung 

- Bees sting reactions, report, 2.6.2005 

- Sun burn: „like a knife in the skin“, report, 5.7.2005 

- Awareness action “sun:watch” at three public baths in Vorarlberg (Bludenz, 

Feldkirch, Bregenz), report, 9.6.2006 

3/2010 

- Pregnant mothers should often stay at farms (for pre-natal allergy prevention), 

interview (for the announcement of the Lake Constanz Symposium), 

10.11.2006 

• Feldkirch aktuell 

- Sun:watch – Felsenau Feldkirch, report, 6/05 

- Sun:watch – Felsenau Feldkirch, Report, 6/07 

• Baby Express 

- Cold protection and children, section: You ask – experts answer, 9/06 

• Arzt & Praxis 

- Management of infected wounds, report, (2008), 62:186-189 

• Das Medizinprodukt 

- Erfolgreiche Reduktion des Juckreizes, report, (2009), 4:36-38 

Feldkirch, March 2010 

39

CURRICULUM VITAE Robert Strohal, MD - EWMA

Create successful ePaper yourself

Delete template?

Save as template?